NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING IN AGROKULTURA AB (PUBL)

NOTICE Shareholders wishing to participate in the meeting must be entered as owners in the shareholders’ register, kept by Euroclear Sweden AB (the Swedish Central Securities Depository & Clearing Organisation), on the record day which is Friday 20 March 2015, and notify the company of their attendance and any assistant no later than the same day (Friday 20 March 2015). Notification can be made via letter to Agrokultura AB, ”Extraordinary general meeting”, Artillerigatan 6, SE-114 51 Stockholm, Sweden or by e-mail to info@agrokultura.com. Notification shall include full name, personal identification number or corporate registration number, address and daytime telephone number and, where appropriate, information about representatives, proxies and assistants. The number of assistants may not be more than two. In order to facilitate entry to the meeting, notification should, where appropriate, be accompanied by powers of attorney, registration certificates and other documents of authority. Personal data obtained from the share register kept by Euroclear Sweden AB, notices and attendance at the meeting and information on representatives, proxies and assistants will be used for registration, preparation of the voting list for the meeting and, where appropriate, the minutes of the meeting. NOMINEE REGISTERED SHARES Shareholders who have their shares registered in the name of a nominee must request temporary entry in the transcription of the share register kept by Euroclear Sweden AB in order to be entitled to participate at the meeting. The shareholder must inform the nominee well in advance of Friday 20 March 2015, at which time the register entry must have been made. PROXY A shareholder represented by proxy shall issue a power of attorney which shall be dated and signed by the shareholder. If issued by a legal entity the power of attorney shall be accompanied by registration certificate or, if not applicable, equivalent documents of authority. Power of attorney forms for those shareholders wishing to participate by proxy are available on the company’s website www.agrokultura.com. The original version of the power of attorney shall also be presented at the meeting. PROPOSED AGENDA 1. Opening of the meeting 2. Election of chairman of the meeting 3. Preparation and approval of the voting list 4. Approval of the agenda 5. Election of one or two persons to verify the minutes 6. Determination whether the meeting has been duly convened 7. Resolution on remuneration to the board of directors 8. Resolution on the number of board members and election of new directors to the board of the company 9. Resolution a) on change of company category from public limited liability company to private limited liability company and b) to amend the articles of association 10. Closing of the meeting SALERMO S.A. AND MAGNA FINANCE INVESTMENTS LIMITED’S PROPOSALS The meeting has been convened on a request by the company’s largest shareholders, Salermo S.A. and Magna Finance Investments Limited (previously Magna Investments Limited). Item 7 - Resolution on remuneration to the board of directors The company’s largest shareholders, Salermo S.A. and Magna Finance Investments Limited, propose that the meeting resolves on remuneration to the board of directors as follows. At the extraordinary general meeting 10 November 2014, it was resolved that the chairman is entitled to SEK 552,000, and the other directors are entitled to SEK 276,000 each. Moreover, SEK 138,000 was to be paid to the chairman of the audit committee. It is proposed that the remuneration to the board members will be adjusted as follows (the indicated amounts state the fees on an annual basis). The board remuneration for the time until the next annual general meeting will be SEK 552,000 to the chairman of the board, and SEK 80,000 to each of the other directors. If the general meeting resolves in accordance with the proposal under item 8, the total remuneration will amount to SEK 712,000, which is a decrease compared to the remuneration resolved upon by the extraordinary meeting on 10 November 2014. The new remuneration levels state the fees on an annual basis, and board remuneration for the time from the entering into force of the resolution under this item 7 until the annual general meeting 2015 will be paid in proportion to the term of office. Board remuneration and remuneration for committee work for the time from the extraordinary general meeting on 10 November 2014 to the entering into force of the resolution under this item 7 will be paid based on the remuneration levels resolved upon by the extraordinary general meeting on 10 November 2014, but in proportion to the term of office. A director may invoice the director’s fee through own company provided that there are tax-related conditions for doing so and that it is cost-neutral for the company. If a director invoices the director’s fee through a company, the fee will be increased by an amount equal to statutory social security contributions. Item 8 - Resolution on the number of board members and election of new directors to the board of the company The company’s largest shareholders, Salermo S.A. and Magna Finance Investments Limited, propose that the meeting resolves on election of new directors to the board as follows. It is proposed that the board will consist of three directors for the time until the end of the next annual general meeting. Mr. Vladimir Kuznetsov is elected as a new director of the board until the end of the next annual general meeting. It is noted that Werner Kuester and Simon Hallqvist will resign from the board and leave their seats for disposal in connection with the meeting. It is further noted that Klaus John shall remain as director of the board and that Achim Lukas shall remain as director and chairman of the board in accordance with the election at the extraordinary general meeting on 10 November 2014. Vladimir Kuznetsov Mr. Kuznetsov is a Russian citizen and from April 2001 to May 2009, Mr. Kuznetsov was the Deputy General Director of the Finance Department of Prodimex Holding, one of the largest corporate farmers in Russia and a major participant in the sugar refining industry in Russia. Since May 2009, Mr. Kuznetsov is the Financial Director of Art Pro LTD, an independent consulting company. Mr. Kuznetsov has a legal and a financial degree. Mr. Kuznetsov does not own any shares in the company. Item 9 - Resolution a) on change of company category from public limited liability company to private limited liability company and b) to amend the articles of association a) The company’s largest shareholders, Salermo S.A. and Magna Finance Investments Limited, propose that the general meeting resolves to change company category from public limited liability company to private limited liability company. The resolution requires that the company’s articles of association are amended. A resolution in accordance with the proposal is valid only if supported by all shareholders represented at the general meeting holding at least nine-tenths of all the shares in the company. The resolution shall be conditioned upon the general meeting’s resolution to amend the articles of association in accordance with the proposal (Item 9 b). b) The company’s largest shareholders, Salermo S.A. and Magna Finance Investments Limited, propose that the general meeting resolves to amend the articles of association by removing “The company is a public limited liability company.” in Section 1 of the articles of association and section 8 in the articles of association regarding notice to attend a general meeting shall be amended as follows. “Notice to attend a general meeting shall be issued by mail to the shareholders. The Board of Directors may before a general meeting resolve that the shareholders are entitled to vote per mail. Notice to attend an annual general meeting and notice to attend an extraordinary general meeting at which the issue of alterations of the articles of association is to be addressed shall be issued not earlier than six weeks and not later than two weeks prior to the meeting. Notice to attend an extraordinary general meeting other than such as mentioned above shall be issued not earlier than six weeks and not later than two weeks prior to the general meeting.” NUMBER OF SHARES AND VOTES IN THE COMPANY The total number of shares in the company at the time of issuance of this notice is 146,263,128. The company does not hold any of its own shares. SHAREHOLDERS’ RIGHT TO REQUEST INFORMATION Shareholders are reminded of their right pursuant to Chapter 7 Section 32 of the Swedish Companies Act to request information from the board of directors and the CEO regarding circumstances which may affect the assessment of an item on the agenda. The Board of Directors Stockholm in February 2015 Agrokultura AB (publ)

Tele2 pushing for new UN Sustainable Development Goals on anti-corruption

Tele2 is a part of the Swedish network; SLSD, which has about 20 member companies, facilitated by Sida (Swedish International Development Cooperation Agency). The network has made a commitment to individually and collectively work to reduce corruption, and to promote ethical business practices in countries where we operate. Marie Baumgarts, Head of Corporate Responsibility, Tele2 AB, comments: “Since the Millenium Development Goals were launched over a decade ago, we have seen a lot of positive developments. However, within the network we felt that one significant challenge remained; goals regarding corruption. Corruption plays an important part in for example poverty and the discrimination of human rights. So within the network we decided to do something about it. When the original millennium goals were set, companies were practically not a part of the process at all. Today, we sit in the front row and are influential. That is what I call progress!” A specific anti-corruption group, including Tele2 AB and Swedfund amongst others, was created. Together the representatives from the companies drafted a document emphasizing the importance of introducing goals regarding anti-corruption which subsequently went into the proposed post 2015 development agenda as sub goals. The sub goals state that member states of the UN shall “substantially reduce corruption and bribery in all its forms” and “develop effective, accountable and transparent institutions at all levels”. The post 2015 agenda is currently under negotiation and shall be adopted in New York on 25 September this year. Charlotte Petri Gornitzka, Director General of Sida, comments: “The importance of private sector engagement for sustainable global development is increasingly being recognized, in Sweden as well as globally. Companies have great potential to address major challenges such as corruption. Sida is working actively to promote this through different models for private sector collaboration." For more information, please contact: Lars Torstensson, EVP Corporate Communication and Strategy, Tele2 AB, Phone: +46 702 73 48 79. Viktor Wallström, Head of Public Relations, Tele2 AB, Phone: +46 703 63 53 27

Fourth quarter 2014 results

EBITDA amounted to USD 239 (-68) million in the quarter and EBIT was USD -184 (-201) million, after recording a net impairment charge of USD 319 (112) million. Net earnings for the fourth quarter were USD -287 (-56) million, translating into an EPS of USD -1.42 (-0.40). Due to the current challenging macro environment, the company is taking steps to strengthen its business to adapt to market conditions and ensure that the company is in a position to benefit when conditions improve. The company is also working to increase its financial flexibility. The company is considering diversifying its capital structure going forward, as well as aligning loan agreements. “The drop in oil prices and the challenging macro environment are influencing our business and the way we work. In response to this, we have initiated a cost-efficiency programme with an ambition to reduce costs by more than USD 100 million in 2015. Moreover, we are working to increase our financial flexibility and optimize the capital structure. We have constructive dialogues with our banks and stakeholders and we are confident that we will be able to fund our planned developments,” says CEO Karl Johnny Hersvik. Johan SverdrupDuring the quarter, the FEED phase was completed for the Johan Sverdrup development, leading up to submission of the plan for development and operation (PDO) in February 2015. This was a major milestone in the project, confirming the timeline to production start-up in 2019. Following this, Det norske’s P50 reserves have more than doubled. The Ministry of Petroleum and Energy is to conclude on the unitization split. Ivar AasenThe Ivar Aasen project continued to move forward in line with expectations, with construction of the topsides in Singapore and the steel jacket in Sardinia progressing well. Drilling of geo-pilot wells commenced in January 2015.ProductionProduction from the Alvheim fields has been stable and higher than forecast throughout the entire quarter. The production availability for the Alvheim FPSO in the fourth quarter was 99.1 per cent, with a production efficiency of 98.8 per cent, which is above target. The production and processing facility on the Alvheim FPSO was modified in the fourth quarter to receive production from the Bøyla field. First oil was achieved in January 2015, on schedule. Production from Jotun, Jette and Varg has been stable during the quarter, except for a shut in on Jotun for a period in December due to maintenance and upgrades. Atla was shut in for a period in November and December due to maintenance on Heimdal. ExplorationA discovery was made at the Krafla North prospect in the North Sea in December. Following drilling of the Krafla Main appraisal well in early 2015 and further evaluation in the licences, the estimate for recoverable resources was increased to 140-220 million barrels of oil equivalent. Find the Q4 2014 report and presentation attached. The presentation will take place at Felix konferansesenter in Oslo at 08:30 a.m. (CET). A live webcast will be available at our website, www.detnor.no (http://www.detnor.no/en/).

ASETEK - Private placement successfully completed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES Oslo, 25 February 2015 Reference is made to the stock exchange notice published on 24 February 2015. Asetek A/S (the "Company", ticker "ASETEK") today announces that it has raised NOK 100 million in gross proceeds through a private placement of 10,000,000 new shares (the “Offer Shares”), each with a par value of DKK 0.10, at a price of NOK 10.00 per share (the “Private Placement”). The Private Placement took place through an accelerated bookbuilding process managed by Arctic Securities AS and Carnegie AS as Joint Bookrunners after close of markets yesterday. The net proceeds from the Private Placement will be used to i) prepare for data center product launches and volume ramp-up during H2 2015 and 2016, including optimization of manufacturing processes and capabilities; ii) strengthen data center business development infrastructure in order to continue to accelerate further OEM adoption; and iii) strengthen the balance sheet in order to support further partnering with Tier 1 OEMs. The completion of the Private Placement is conditional upon approval by an extraordinary general meeting of the Company, expected to be held on or about 19 March 2015 (the "EGM"). Notification of conditional allotment for the Private Placement will be sent to the applicants today through a notification to be issued by the Joint Bookrunners. The Offer Shares will be settled through delivery versus payment immediately after the registration of the share capital increase following the EGM. Admission to listing and trading of the Offer Shares on the Oslo Stock Exchange is subject to the approval of the Prospectus by the Financial Supervisory Authority of Norway, which is expected on or about 24 March 2015. The Private Placement was well subscribed at the issue price and was supported by both existing shareholders as well as new investors. The waiver of the preferential rights inherent in a private placement with such participation is considered necessary in the interest of time and in order to ensure the new equity at favorable terms. The Board of Directors will propose to the EGM to conduct a subsequent offering of up to 2,000,000 new shares directed towards the Company’s shareholders as of 24 February 2015 (as documented by the shareholder register in the Norwegian Central Securities Depository (VPS) on 26 February 2015) who were not allocated shares in the Private Placement (the “Subsequent Offering”). The subscription price in the Subsequent Offering will be equal to the subscription price in the Private Placement.   Following registration of the new share capital pertaining to the Private Placement in the Danish Business Authority, the Company will have 24,881,311 shares outstanding, each with a par value of DKK 0.10. For further information, please contact:André S. Eriksen, Chief Executive OfficerMobile: +45 2125 7076, e-mail: ceo@asetek.com Important information: The release is not for publication or distribution, in whole or in part directly or indirectly, in or into Australia, Canada, Japan or the United States (including its territories and possessions, any state of the United States and the District of Columbia). This release is an announcement issued pursuant to legal information obligations, and is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. It is issued for information purposes only, and does not constitute or form part of any offer or solicitation to purchase or subscribe for securities, in the United States or in any other jurisdiction. The securities mentioned herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act"). The securities may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act. The Company does not intend to register any portion of the offering of the securities in the United States or to conduct a public offering of the securities in the United States. Copies of this announcement are not being made and may not be distributed or sent into Australia, Canada, Japan or the United States. The issue, exercise, purchase or sale of subscription rights and the subscription or purchase of shares in the Company are subject to specific legal or regulatory restrictions in certain jurisdictions. Neither the Company nor the Managers assume any responsibility in the event there is a violation by any person of such restrictions. The distribution of this release may in certain jurisdictions be restricted by law. Persons into whose possession this release comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. Arctic Securities and Carnegie are acting for the Company and no one else in connection with the Private Placement and the Subsequent Offering and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to the Private Placement and the Subsequent Offering and/or any other matter referred to in this release. Forward-looking statements: This release and any materials distributed in connection with this release may contain certain forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they reflect the Company's current expectations and assumptions as to future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. ***

Fourth quarter and year-end report 2014

Fourth quarter compared to the same period 2013 · Net sales decreased by 4 percent to 1,252.0 (1,306.8) MSEK, and by 6 percent at constant FX, with a decline in Norway and higher sales from Sweden and Denmark. · Adjusted*operating income increased to 79.6 (77.0) MSEK, corresponding to an improved margin of 6.4 (5.9) percent. · Adjusted* income for the period increased to 48.1 (16.5) MSEK, and adjusted* earnings per share were 0.80 (0.33) SEK. · Adjusted* operating cash flow improved to 64.5 (-53.2) MSEK. Full year 2014 compared to pro forma 2013 · Net sales increased by 1 percent to 5,267.2 (5,192.4) MSEK, and were flat at constant FX, with strong growth in Sweden and higher sales in Denmark offsetting lower sales in Norway. · Adjusted* operating income decreased to 301.0 (317.2) MSEK corresponding to a margin of 5.7 (6.1) percent, due to the termination of a major contract in Norway as of 1 April 2014. · Adjusted* income for the period increased to 145.1 (89.2) MSEK and adjusted*earnings per share rose to 2.63 (1.78) SEK, positively impacted by lower finance expenses following the refinancing of bank loans in July 2014. · Adjusted* operating cash flow improved to 438.1 (176.1) MSEK, helped by a reduction of inventories compared to an increase in the previous year. · The Board of Directors proposes a dividend for 2014 of 1.30 (-) SEK per share. *) Adjusted for non-comparable items of -6.1 (-19.8) MSEK in operating income in Q4 and -62.5 (-154.3) MSEK   for the full year 2014. For further details on the non-comparable items, see page 4. CEO Statement Net sales for the full year 2014 were slightly up overall, with higher sales in Sweden and Denmark offsetting a decline in Norway following the termination of the ICA Norway contract as of 1 April 2014. Excluding this contract, net sales rose by 7 percent in local currency. The retail market for chicken products in Scandinavia increased by approximately 3 percent* in value for the full year. Group sales increased ahead of the retail market in Sweden and Denmark but behind in Norway. Adjusted operating income and margin for the full year were lower than 2013 pro forma due to the loss of the ICA Norway contract. The impact of the loss of this contract was to a large extent offset by a strong performance in Sweden and operational cost-savings. In the fourth quarter both operating income and margin improved, benefitting from cost-savings and a more favourable inventory position than last year. The refinancing of the bank loans in July at lower interest rates led to significantly lower finance expense. As a result, adjusted income for the period and adjusted earnings per share increased strongly both for the quarter and the full year. Adjusted operating cash flow showed a substantial improvement for the full year, helped by inventory reductions this year compared to increases last year. Net sales in Sweden showed strong growth and the adjusted operating income and margin improved both for the quarter and the full year. In Denmark, net sales and adjusted operating income also increased for both periods. In Norway, the process to replace the sales lost on the ICA Norway contract has taken longer than anticipated. The decline in net sales in Norway was more pronounced in the fourth quarter as the whole retail market for chicken products was affected by extensive media coverage regarding bacteria in chicken. The media focus has continued into 2015 with an ongoing negative impact on demand for chicken products. This, in combination with the loss of the ICA contract, will impact negatively in 2015. In Scandi Standard we go to great lengths to safeguard the healthiness of our products and we believe that chicken products in Norway, as well as in Sweden and Denmark, are among the healthiest in the world. Scandinavian chicken products are generally regarded as being of the highest quality due to the strict standards applied on matters of animal health and welfare and the fact that neither antibiotics nor growth hormones are used in the feed process. Our product innovation programme delivered a number of successful product launches in the year. We will continue to increase our efforts in this area going forward to support our vision of Scandinavians eating chicken at least once more per week. The acquisition of Bosarpskyckling is a valuable addition to the Group in this respect as it creates a new platform for growth in the premium organic segment. We are now looking to increase the number of external farms that are able to supply organic chicken. Our actions to improve operational efficiency continued as planned. The number of chickens processed per employee per day in our main plant in Sweden increased by 26 percent from 2013. In Norway, we managed to reduce operating costs but the number of chickens processed per employee and day declined by 16 percent because of the sharp fall in sales volumes. The lower cost base creates a good platform for improved efficiency in production going forward. We made good progress in many areas during 2014 and strengthened our position as the market leader in chicken-based food products in Scandinavia. The adjusted operating income for the Group was below our initial expectations due to the decline in sales in Norway, but this has not caused us to change our medium-term financial targets communicated in June 2014. Leif Bergvall HansenManaging Director and CEO For further information, please contact: Leif Bergvall Hansen, Chief Executive Officer,   Tel: +45 22 10 05 44Jonathan Mason, Chief Financial Officer,           Tel: +45 22 77 86 18Patrik Linzenbold, Head of Investor Relations, Tel: +46 708 25 26 30This interim report comprises information which Scandi Standard is required to disclose under the Securities Markets Act and/or the Financial Instruments Trading Act. It was released for publication at 07:30 CET on 25 February 2015.

ASETEK – Ex Subsequent Offering today 25 February 2015

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES Oslo, 25 February 2015 Reference is made to the stock exchange notice published by Asetek A/S (the “Company”, ticker "ASETEK") today regarding the completed Private Placement. The Company’s shares will trade exclusive the right to participate in the subsequent offering from and including today, 25 February 2015. Important information: The release is not for publication or distribution, in whole or in part directly or indirectly, in or into Australia, Canada, Japan or the United States (including its territories and possessions, any state of the United States and the District of Columbia). This release is an announcement issued pursuant to legal information obligations, and is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. It is issued for information purposes only, and does not constitute or form part of any offer or solicitation to purchase or subscribe for securities, in the United States or in any other jurisdiction. The securities mentioned herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act"). The securities may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act. The Company does not intend to register any portion of the offering of the securities in the United States or to conduct a public offering of the securities in the United States. Copies of this announcement are not being made and may not be distributed or sent into Australia, Canada, Japan or the United States. The issue, exercise, purchase or sale of subscription rights and the subscription or purchase of shares in the Company are subject to specific legal or regulatory restrictions in certain jurisdictions. Neither the Company nor the Managers assume any responsibility in the event there is a violation by any person of such restrictions. The distribution of this release may in certain jurisdictions be restricted by law. Persons into whose possession this release comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. Arctic and Carnegie are acting for the Company and no one else in connection with the Private Placement and the Subsequent Offering and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to the Private Placement and the Subsequent Offering and/or any other matter referred to in this release. Forward-looking statements: This release and any materials distributed in connection with this release may contain certain forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they reflect the Company's current expectations and assumptions as to future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. ***

ASETEK – Q4 2014: Building momentum within data center liquid cooling

February 25, 2015 – Total revenues for 2014 were $20.8 million, on par with 2013. Fourth quarter revenues were $4.6 million, versus $6.1 million the same period last year. Asetek expects strong quarter-on-quarter revenue growth for the first and second quarter of 2015, mainly driven by the release of its Generation 5 platform of products. During 2014, Asetek continued to invest in its growth strategy targeting large-scale adoption of liquid cooling of data centers. In February 2015, The California Energy Commission selected Asetek for a $3.5 million project to install RackCDU liquid cooling in two data centers. Yesterday, Asetek announced a global OEM purchase agreement with Fujitsu. Fujitsu will incorporate Asetek’s RackCDU liquid cooling technology into its high performance computing server product line and is expected to launch the first products in the second quarter of 2015. Intellectual property is a key part of Asetek’s growth platform. In December 2014, the U.S. District Court unanimously ruled in favor of Asetek on all claims in its patent infringement lawsuit against CMI USA, Inc and in February 2015, the patent case with CoolIT Systems Inc. (“CoolIT”) was settled. “We spent 2014 building momentum with continued data center and IP investments, and achieved progress with existing and potential partners. We are very pleased that our strategic efforts over the last couple of years are yielding results. When we now strengthen our balance sheet, we are preparing for accelerated growth with data center volume ramp-up and further partnering with top tier OEMs”said André Sloth Eriksen, founder and CEO of Asetek. Fourth quarter material The fourth quarter report and the webcast presentation are attached to this release and available from the company’s website www.asetek.com. WebcastAsetek will give a presentation today at 08:30 CET which can be followed through a webcast or a conference call. CEO André Eriksen and CFO Peter Dam Madsen will represent the company. A link to the webcast can be accessed from asetek.com/investor-relations/reports-presentations. The conference call details are: +----------------------------------+-------------------+|Oslo, Norway |+47 2350 0486 |+----------------------------------+-------------------+|Copenhagen, Denmark |+45 32 71 16 59 |+----------------------------------+-------------------+|London, United Kingdom |+44 (0)20 3427 1915|+----------------------------------+-------------------+|New York, United States of America|+1 646 254 3367 |+----------------------------------+-------------------+| | |+----------------------------------+-------------------+|Confirmation Code: |7385201 |+----------------------------------+-------------------+ Q&A The conference call lines will be opened for participants to ask questions at the end of the presentation. For further information, please contact:Andre S. Eriksen, Chief Executive OfficerMobile: +1 408 398 7437, e-mail: ceo@asetek.com Peter Dam Madsen, Chief Financial OfficerMobile: +1 408 813 4147, e-mail: investor.relations@asetek.com

Frequent sauna use protects men against cardiac death

Frequent – even daily – taking a sauna can reduce the risk of cardiac death, according to a recent study carried out at the University of Eastern Finland. The 20-year follow-up study discovered that men taking a sauna 4-7 times a week were 63% less likely to experience a sudden cardiac death than those taking a sauna once a week. Furthermore, the occurrence of death due to coronary artery disease and other cardiac events, as well as overall mortality, were less frequent in the group taking saunas several times a week. The effects of sauna use on mortality were studied in the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD), involving more than 2,000 middle-aged men living in the eastern part of Finland. Based on their sauna-taking habits, the study participants were divided into three groups: those taking a sauna once a week, those taking a sauna 2-3 times a week, and those taking a sauna 4-7 times a week. The more frequently saunas were taken, the less likely were sudden cardiac deaths, deaths due to coronary artery disease and other cardiac events, as well as deaths due to other reasons. Moreover, the time spent taking a sauna was linked to the risk of cardiac death. Those who spent more than 19 minutes in the sauna at a time were 52% less likely to experience a sudden cardiac death than those spending only 11 minutes in the sauna at a time. The risk of death due to a cardiac event was also otherwise smaller in those spending longer times in the sauna. According to Docent Jari Laukkanen, the study leader, the mechanisms of why taking a sauna protects the heart are not yet fully understood, and further research is still required. However, taking a sauna may reduce blood pressure and maintain blood vessel elasticity. The findings were published in JAMA Internal Medicine.  For further information, please contact: Docent Jari Laukkanen, University of Eastern Finland, Institute of Public Health and Clinical Nutrition, tel. +358505053013, jariantero.laukkanen (at) uef.fi

Cecilia Lager and Anna Settman nominated to Eniro’s Board of Directors

Cecilia Lager and Anna Settman will strengthen the Board of Eniro with additional competence and experience in digital products and services as well as in business and financial control. “As Chair of Eniro’s Nomination Committee, I am happy to nominate Cecilia Lager and Anna Settman as directors on Eniro’s board. Their experience is a good fit with the competence that Eniro’s board has today, and with these two new members the new board will have a favorable composition for Eniro’s continued development,” comments Ulric Grönvall, Nomination Committee chair. Cecilia Lager (born 1963) currently serves as a director on several companies’ boards. Her board assignments are in both listed and unlisted companies, such as Elanders AB, Knowit AB, Cinnober Financial Technology AB, Altor Fund Manager AB and Navigera AB. Cecilia Lager has many years of experience from strategic change processes, marketing and communications, and from the finance sector, and has held senior positions for Alecta, SEB and ABB, among others. Anna Settman (born 1970) has extensive experience from the media and communication industry, with 15 years in the management of Aftonbladet Hierta, three of which as CEO. Sheis also a former member of the executive management of Schibsted Sverige. Anna is currently a founding partner of The Springfield Project, a newly established accelerator for Swedishstart-ups. Anna Settman has experience from board assignments in both listed and unlisted companies and is currently engaged in Nordnet Bank, Hyper Island and Anticimex, among others.

ASSA ABLOY acquires MSL in Switzerland

ASSA ABLOY has signed an agreement to acquire MSL Schloss und Beschlägefabrik AG, a leading Swiss supplier of innovative locks. "I am very pleased to welcome MSL into the ASSA ABLOY Group. This acquisition delivers on our strategy to strengthen our position in the mature markets through adding complementary market segments and products", said Johan Molin, President and CEO of ASSA ABLOY. "MSL stands for innovative lock technology", said Tzachi Wiesenfeld, Executive Vice President of ASSA ABLOY and head of the EMEA division. “It has continually shown its success thanks to its high product quality and competent and dedicated employees. MSL will fill in a gap in our product portfolio in the important Swiss market, making ASSA ABLOY more relevant to our Swiss distributors.” MSL was founded in 1892 and has 106 employees. Its head office and factory is located in Kleinlützel near Basel, Switzerland. Sales for 2015 are expected to reach CHF 20 M (approx. SEK 180 M) in the financial year ending 30 June 2015. The acquisition will be accretive to EPS from start. The transaction is expected to close during Q2 2015. For more information, please contact:Johan Molin, President and CEO, tel no: +46 8 506 485 42Carolina Dybeck Happe, CFO and Executive Vice President, tel no: +46 8 506 485 72 About ASSA ABLOYASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user needs for security, safety and convenience. Since its formation in 1994, ASSA ABLOY has grown from a regional company into an international group with about 44,000 employees, operations in more than 70 countries and sales close to SEK 57 billion. In the fast-growing electromechanical security segment, the Group has a leading position in areas such as access control, identification technology, door automation and hotel security.

Notice to attend the Annual General Meeting

PROPOSED AGENDA 1.     Opening of the meeting.2.     Election of chair of the meeting.3.     Preparation and approval of voting register.4.     Adoption of agenda.5.     Election of two persons to check the minutes of the meeting.6.     Determination of whether the meeting has been duly convened.7.     Speech by the CEO.8.     A description by the chair of the Board of Directors of the work of the Board of Directors and the board committees during 2014.9.     Presentation of the annual report, the auditor’s report, the consolidated financial statements and the auditor’s report on the consolidated financial statements for 2014.10.  Resolution on: a)    adoption of the income statement and balance sheet, as well as the consolidated income statement and the consolidated balance sheet for 2014, b)    appropriation of the Company’s result as shown on the adopted balance sheet and setting of record date for the dividend, c)    discharge of the directors and the CEO from personal liability towards the Company for the administration of the Company in 2014. 11.  Resolution on number of directors and alternate directors to be elected at the meeting.12.  Resolution on remuneration payable to the directors.13.  Election of chair of the Board of Directors, directors and any alternate directors.14.  Resolution on number of auditors and deputy auditors.15.  Resolution on remuneration payable to the auditor.16.  Election of auditor and any deputy auditors.17.  Resolution regarding the nomination committee.18.  Resolution on guidelines for remuneration to senior executives.19.  Shareholder’s proposal regarding split of Eniro.20.  Closing of the meeting.   A complete version of the notice is available in the attached document. The English text is an unofficial translation of the Swedish original. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

The first order for a mask writer based on Mycronic´s replacement strategy

Täby, 25 February, 2015 – Mycronic AB (publ) has received an order for a mask writer replacing an older system for manufacturing of display photomasks from a customer in Asia. It is estimatedthat the system will be delivered during the first half of 2016. Mycronic offers mask writers for the manufacturing of photomasks within different fields of application. These areas are display manufacturing (for TV, smart phones and tablets among other things) and applications within the multi-purpose market, a broad segment comprising many different application areas.Ever since the mid 1990s, Mycronic has been delivering mask writers for production of photomasks that are necessary in the manufacturing process for all flat screen displays. Mycronic occupies a unique position as the only supplier in the world of equipment for manufacturing of advanced photomasks. Since the year 2000, Mycronic has delivered approximately 65 mask writers for display applications. A little more than half of these are 10 or more years old. Maintaining these systems is increasingly a challenge. Some of Mycronic's customers with older mask writers also need to modernize their production equipment. To offer customers a wider choice, Mycronic has established a replacement strategy to address the needs described above. Mycronic offers a scalable system, built on the Prexision platform, in exchange for an older system. This offering allows customers to increase productivity. At the same time a long-term service solution is secured for the customer.”This is the first mask writer we are delivering to a customer in exchange for one of their older systems. The mask writer is scalable, which provides the customer with the possibility to further upgrade the mask writer later on,” says Magnus Råberg, Senior VP & General Manager for business area PG at Mycronic AB. “It is gratifying to present an offering that addresses several of the challenges that our customers are facing." The price level for a replacement mask writer built on the Prexision platform is normally in the range of USD 12–16 million depending on the configuration and type of machine traded in. Contacts at Mycronic: Contacts at Mycronic:Magnus RåbergSr VP & General Manager PGTel: +46 8 638 52 00magnus.raberg@mycronic.comPer EkstedtCFOTel: +46 8 638 52 00per.ekstedt@mycronic.com About Mycronic ABMycronic AB is a Swedish high-tech company engaged in the development, manufacture and marketing of production equipment to the electronics industry. Mycronic headquarters is located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany Japan, Singapore, South Korea, Taiwan, the Netherlands, United Kingdom and the United States. For more information see our web site at: www.mycronic.com  Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR. Mycronic is publishing this information in accordance with the Financial Instruments trading Act and/or the Swedish Securities Markets Act. The information was submitted for publication on 25 February, 2015, at 08.00.

Nexam Chemical Holding AB (publ) Year-End Report 1 January – 31 December 2014

Operations: ·As of 1 January 2015 Anders Spetz has been appointed new CEO of Nexam Chemical. ·NEXIMID® MHT-R, a new resin for high temperature applications, has been launched. ·NEXAMITE® PBO, a multifunctional additive, has been introduced on the market. ·Nexam Chemical and BASF have jointly decided not to extend the exclusivity agreement which expires in May 2015. This enables Nexam Chemical to collaborate with other partners regarding nylon-66. ·The exclusivity agreement with Armacell has been extended after delays in the developing process. This is a result of a strategic decision made by Armacell to switch over to recycled PET. ·The rPET project, partly financed by Eurostar, began during the quarter as a collaboration with Armacell and The European Van Company. The aim of the projcect is to develop a product that can help PET and recycled PET to be upgraded for use in, e.g. sandwich composites for production of vehicle bodies. Financial & legal: ·Net sales for the fourth quarter totalled SEK 642,000 (1,707,000). Profit/loss before tax for the period amounted to SEK -10,446,000 (-8,126,000). ·Total assets at the end of the period amounted to SEK 84,880,000 (54,516,000), with cash and cash equivalents accounting for SEK 62,543,000 (32,511,000). ·The net cash flow for the fourth quarter was SEK -8,961,000 (-7,172,000). Key events after end of the period ·The Management and key persons in the company has subscribed for a total of 700,000 warrants. ·Christian Svensson, acting CFO since August 2014, has been employed. ·Two new patents has been approved. In the US, for a new process of manufacturing EBPA and in Europe for catalysis of crosslinking. Lund, 25 February 2015Board of Directors These financial statements have not been audited by the Company's auditor.  This Year-End Report is published in Swedish and English. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For more information, please contact:Lennart Holm, Chairman of the Board: +46 (0)706 30 8562Anders Spetz, CEO, +46 (0)703 47 97 00

Tanzanians to enjoy Africa’s first universal mobile money service

The agreement means that four million Tigo Pesa users will for the first time be able to exchange money with six million M-Pesa customers in Tanzania later this year. They will be able to do this in the same way that they do already with Airtel and Zantel customers following the launch of similar services with Tigo in 2014. These were the first examples of such “interoperability” in Africa. Commenting on the announcement today, Millicom’s Executive Vice President for Africa, Arthur Bastings, said “With Tigo Pesa customers will now have Africa’s first universal mobile money exchange system. They will be able to safely and securely transact with millions more people across the country. It’s another first for Tigo Pesa and Tanzania. Following the success of the service with Airtel and Zantel, we hope many more Tanzanians will choose mobile money so that everyone benefits and we can extend financial inclusion even further. We also intend to pioneer similar agreements with networks elsewhere.”  The initiative with M-Pesa follows a series of Tigo Pesa innovations within the last year which have included: -           cross-border mobile money exchange with currency conversion included -           the first inter-network mobile money exchange with Airtel in 2014 and -           quarterly returns on Tigo Pesa balances. Millicom’s Tigo mobile money services have been shortlisted for an award for their innovation at next week’s GSMA annual global mobile industry event in Barcelona.

Notice of Annual General Meeting of NeuroVive Pharmaceutical AB (publ)

Read notice in pdf: Notice of General Meeting eng (http://mb.cision.com/Public/6574/9730098/891531a903ed4d99.pdf) Entitlement to participate and notificationShareholders that wish to participate at the Annual General Meeting should• be included in the share register maintained by Euroclear Sweden AB on Tuesday 24 March 2015, and• notify the Company in writing by no later than Tuesday, 24 March 2015 to NeuroVive Pharmaceutical AB, Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden. Such notification is also possible by telephone +46 (0)46 275 6220 or fax +46 (0)46 888 8348 or by email: info@neurovive.com. Notifications must state full names, personal or corporate identity numbers, shareholdings, address, daytime telephone number, and where applicable, information on deputies or assistants (maximum of two). Where applicable, notifications should also enclose powers of attorney, certificates of registration and other legitimacy papers. Nominee-registered sharesFor entitlement to participate at the Annual General Meeting, shareholders with nominee-registered holdings with banks or other administrators must temporarily re-register their shares in their own name with Euroclear Sweden AB. Such re-registration must be complete by no later than Tuesday, 24 March 2015, which means that shareholders that wish to conduct such re-registration must inform their administrator thereof in good time prior to the aforementioned date.Proxies etc.If shareholders attend by proxy, such proxy must bring a written power of attorney, dated and signed by the shareholder to the Meeting. This power of attorney may not be older than one year, unless a longer term of validity (although subject to a maximum of five years) is stated in the power of attorney. If the power of attorney has been issued by a legal entity, the proxy should also bring the relevant certificate of registration or corresponding legitimacy papers for the legal entity. To facilitate entry, a copy of the power of attorney and other legitimacy papers should be attached to the notification of attendance of the Meeting. Power of attorney forms are available from the Company’s website www.neurovive.se and can be sent by mail to shareholders that contact the Company stating their mail address. Number of shares and votes At the time of publication of this Notice, the total number of shares and votes of the Company is 27,788,093. Additionally, 1,300,000 shares have been subscribed and allocated in the company's recently completed private placement. The Company does not hold any treasury shares. Proposed agenda:0. Opening the Meeting.1. Election of a Chairman of the Meeting.2. Preparation and approval of the voting list.3. Approval of the agenda.4. Election or two persons to verify the minutes.5. Consideration of whether the Meeting has been duly convened.6. Chief Executive Officer's address.7. Submission of the Annual Accounts and Audit Report and the Consolidated Accounts and Consolidated Audit Report.8. Resolutions a) On adopting the Income Statement and Balance Sheet and the Consolidated Income Statement and Consolidated Balance Sheet. b) On appropriation of the Company's earnings in accordance with the adopted Balance Sheet. c) On discharging the Board members and Chief Executive Officer from liability.9. Determination of the number of Board members10. Determination of Directors' and audit fees.11. Election of a Board of Directors.12. Resolution on guidelines for remuneration to senior executives.13. Resolution on guidelines for the Nomination Committee.14. Resolution on authorizing the Board of Directors to decide on the new issue of shares. 15. Closing the Meeting. Proposed resolutions in brief: Election of a Chairman of the Meeting (point 1)The Nomination Committee proposes that the Annual General Meeting appoints Andreas Sandgren as Chairman of the Meeting. Appropriation of profits (point 8 b)The Board of Directors proposes that the Annual General Meeting disposes over the Company’s earnings in accordance with the Board of Directors’ proposal in the Annual Accounts. Additionally, the Board of Directors proposes that no dividend is paid for the financial year 2014.Determination of the number of Board members and determination of Directors’ and audit fees (point 9 and 10)The Nomination Committee proposes that the Annual General Meeting resolves that the number of Board members shall be eight. The Nomination Committee also proposes that fees to Board members elected by the Annual General Meeting not employed by the Company and members of the Board of Directors’ various Committees not employed by the Company shall be payable as follows: • SEK 300,000 to the Chairman of the Board;• SEK 150,000 each to other Board members;• SEK 100,000 to the Chairman of the Audit Committee;• SEK 50,000 each to other members of the Audit Committee;• SEK 40,000 to the Chairman of the Remuneration Committee;• SEK 20,000 each to other members of the Remuneration Committee. Having considered the Company’s and the Board of Directors’ appraisal of the auditors’ work, the Nomination Committee proposes that as in the previous year, audit fees should be in accordance with approved account pursuant to customary billing terms. No fees shall be payable to members of the Nomination Committee. Election of the Board of Directors (point 11)The Nomination Committee proposes that the Annual General Meeting approves re-election of the following Board members: Greg Batcheller, Arne Ferstad, Boel Flodgren, Marcus Keep, Helena Levander, Anna Malm Bernsten and Helmuth von Moltke. The Nomination Committee also proposes the election of Fredrik Olsson as a Board member. The Nomination Committee proposes that Greg Batcheller is re-elected as Chairman of the Board.Resolution on guidelines for remuneration to senior executives (point 12)The Board of Directors proposes that the Annual General Meeting approves the following guidelines for senior executives:Guidelines for remuneration and other employment terms for management primarily imply that the Company should offer its senior executives market remuneration, that the remuneration shall be subject to consultation by a dedicated Remuneration Committee within the Board of Directors, that the associated criteria shall constitute the senior executive’s responsibilities, role, competence and position. Remuneration to senior executives decided by the Board of Directors excluding any Board members affiliated to the Company and management. The guidelines shall be applied to new agreements, or existing agreements reached between senior executives after the guidelines have been adopted, and until new or revised guidelines are determined. What is stipulated for NeuroVive also applies to the Group, where applicable. This proposal is basically identical to the guidelines approved for remuneration to senior executives in the previous year. 1. Basic principleSalary and other benefits, as well as any share-related incentive programs, shall be on market terms and shall be structured so that NeuroVive can attract and retain competent senior executives. 2. Fixed compensationSenior executives shall be offered fixed compensation that is on market terms and based on the senior executive's responsibilities, roll, competence and position. Fixed compensation shall be subject to annual review. 3. Variable remunerationFrom time to time, senior executives may be offered variable remuneration. Such variable remuneration shall be on market terms and shall be based on the outcome of predetermined financial and individual targets. The terms and conditions and basis of computation of variable remuneration shall be determined for each financial year. Variable compensation is settled in the year after vesting and may either be paid as salary or as a lump-sum pension premium. Payment as a lump-sum pension premium is subject to indexation so the total cost for NeuroVive is neutral. The basic principle is that the yearly variable remuneration portion may amount to a maximum of 30% of fixed annual compensation. The total of the variable remuneration for senior executives may amount to a total maximum of SEK 1,500,000. When structuring variable remuneration that is payable to management in cash, the Board of Directors should consider introducing provisions such as: a.) making payment of a predetermined portion of such remuneration conditional so the performance on which vesting is based is demonstrably sustainable over time, andb.) offers the Company the opportunity to reclaim such remuneration paid on the basis of information that subsequently proves manifestly erroneous. 4. Non-monetary benefitsWhere the Board of Directors considers it appropriate and/or after individual consideration of an overall salary and benefits structure, a senior executive may be entitled to additional healthcare insurance. 5. PensionSenior executives are entitled to market-based pension solutions in accordance with collective bargaining agreements and/or agreements with NeuroVive. All pension obligations should be defined contribution. Salary waivers may be utilized to increase pension provisions through lump-sum pension premiums, providing the total cost for NeuroVive is neutral. 6. Notice periodFrom NeuroVive’s side, the maximum notice period shall be six months for the Chief Executive Officer and a maximum of six months for other senior executives. The notice period from the Chief Executive Officer’s side shall be a minimum of six months, and from other senior executives’ side, shall be a minimum of three months. 7. The consultative and decision-making process of the Board of DirectorsThe Board of Directors' Remuneration Committee consults on proposals for decision regarding salary and other employment terms for senior executives. Remuneration to senior executives is then decided by the Board of Directors, excluding any Board members who are affiliated to the Company and its management. Share-related incentive programs approved by shareholders’ meetingsThrough its Nomination Committee, the Board of Directors shall consider the need for share-related incentive programs yearly, and where necessary, submit a proposal for resolution to the Annual General Meeting regarding a well-considered share-related incentive program for senior executives and/or other employees. Resolutions regarding any share and share price-related incentive programs targeted at senior executives shall be made by shareholders’ meetings. 8. Information on previously approved remuneration that is not due for paymentThere is no previously approved remuneration that is not due for payment. 9. Information on departure from the guidelines resolved by the Annual General MeetingThere have been no departures from previously approved guidelines. 10. OtherThe Board of Directors shall be entitled to depart from the above guidelines if the Board of Directors judges that there are special circumstances justifying this in an individual case. Resolution on the guidelines for the Nomination Committee (point 13) The Nomination Committee proposes that the work of the Nomination Committee for the Annual General Meeting 2016 should be conducted as follows: • The Company shall have a Nomination Committee that shall consist of a member for each of the three largest shareholders in terms of votes, based on the shareholder statistics as of 30 June 2015, which the Company obtains from Euroclear Sweden AB. If such shareholder does not exercise its right to appoint a member, the right to appoint a member of the Nomination Committee shall transfer to the next largest shareholder in terms of votes. Coincident with the appointment of a new Nomination Committee, in an appropriate manner, the Chairman of the Board shall contact the three largest shareholders identified and request them to nominate the person said shareholder intends to appoint as a member of the Nomination Committee in writing within a reasonable period in the circumstances, although not exceeding 30 days. The majority of the Nomination Committee's members should be non-affiliated to the Company and its management. The Chief Executive Officer or other member of management should not be a member of the Nomination Committee. At least one of the members of the Nomination Committee should be non-affiliated to the largest shareholder of the Company in terms of votes, or group of shareholders that cooperate on the Company’s administration. Board members may be members of the Nomination Committee, but should not constitute a majority of Nomination Committee members. The Chairman of the Board or other Board members should not be the Chairman of the Nomination Committee. If more than one member is a member of the Nomination Committee, a maximum of one of these people should be affiliated to the Company’s largest shareholder. Information on the definitively appointed Nomination Committee shall include the name of the three appointed members, as well as the name of those shareholders that appointed them, and shall be published by no later than six months prior to the scheduled Annual General Meeting. The Nomination Committee’s term of office extends until a new Nomination Committee has been appointed. Unless the members agree otherwise, the chairman of the Nomination Committee should be that member appointed by the largest shareholder in terms of votes. • If one or more of the shareholders that have appointed members of the Nomination Committee are no longer one of the three largest shareholders in terms of votes, members appointed by such shareholders shall put their places on the Nomination Committee at the Committee’s disposal, and that, or those, shareholders that have become one of the three largest shareholders in terms of the vote shall be entitled to appoint members. However, unless there are special circumstances, there shall be no changes to the composition of the Nomination Committee if only marginal changes to the number of votes have occurred, or any such change occurs later than two months prior to the Annual General Meeting. Shareholders that have appointed members of the Nomination Committee are entitled to dismiss such member, and appoint a new member of the Nomination Committee if the member appointed by said shareholder decides to leave the Nomination Committee. Changes to the composition of the Nomination Committee shall be published as soon as they have occurred. • The Nomination Committee shall prepare proposals on the following issues to be submitted to the Annual General Meeting for resolution: a) a proposal regarding a Chairman of the Meeting;b) a proposal regarding the number of Board members elected by the Annual General Meeting, and where applicable, the number of auditors;c) a proposal regarding fees to Board members not employed by the Company, and members of the Board’s various Committees not employed by the Company;d) a proposal regarding audit fees;e) a proposal regarding election of the Chairman of the Board and other Board members, and where applicable, election of auditors;f) a proposal regarding guidelines for appointing members of the Nomination Committee, and for the duties of the Nomination Committee;g) a proposal regarding fees to members of the Nomination Committee. Resolution on authorization for the Board of Directors to decide on the new issue of shares (point 14)The Board of Directors proposes that the Annual General Meeting resolves to authorize the Board of Directors to decide on the new issue of shares, with or without waiving the preferential rights of shareholders on one or more occasions in the period until the next Annual General Meeting.The number of shares issued through this authorization may correspond to an increase of share capital of a maximum of fifteen per cent (15%) based on the total share capital of the Company at the time of the Annual General Meeting 2015. Share issues should be at market subscription price, subject to reservation for a market discount where applicable, and apart from cash, payment may be as assets contributed in kind or through offset or subject to other terms and conditions. A new share issue decided with this authorization should be conducted with the aim of raising working capital for the Company. If the Board of Directors decides on a share issue waiving shareholders' preferential rights, the reason should be to raise working capital for the Company and/or for new owners of strategic significance to the Company and/or acquisitions of other companies or operations. For validity, resolutions require the proposal to be supported by shareholders representing at least two-thirds of the votes cast and shares represented at the Meeting.OtherThe Annual Accounts and Audit Report of the Company and Group, as well as complete proposals for resolution and the auditor's statement pursuant to chap. 8, § 54 of the Swedish Companies Act, will be available at the Company's offices, Medicon Village, Scheelevägen 2, Lund, Sweden, and at the Company’s website www.neurovive.se by no later than three weeks prior to the Annual General Meeting, and will be sent to those shareholders that so request and state their mail address. Shareholders attending the Annual General Meeting are entitled to request disclosures regarding matters on the agenda or the Company’s or Group’s financial position in accordance with chap. 7 § 32 of the Swedish Companies Act (2005:551) THE BOARD OF DIRECTORSNeuroVive Pharmaceutical AB (publ)Lund, Sweden, February 2015 N.B. English translation is for convenience purposes only. NeuroVive Pharmaceutical AB (publ) is required to publish the information in this news release under The Swedish Securities Market Act. The information was submitted for publication on 25 February 2015, at 8:30 a.m. CET.

Martina Merz and Eckhard Cordes proposed as new Board members of AB Volvo

Martina Merz, 51, recently relinquished her position as CEO of the global brake manufacturer Chassis Brakes International. Prior to that, she worked for nearly 25 years with Robert Bosch GmbH, most recently as head of marketing and sales at the Chassis System Brakes division. Martina Merz has long experience of the automotive industry and is currently a member of the Board of SAF Holland S.A, a subcontractor to the truck and bus industry. She holds a BS in mechanical engineering from the University of Cooperative Education in Stuttgart. Eckhard Cordes, 64, has devoted most of his active professional life to the automotive industry. For nearly 30 years, he has held a number of management positions with Daimler Benz, including head of the company’s truck and bus operations. Eckhard Cordes has also been a member of several boards of directors, including Air Berlin, SKF, Carl Zeiss and Rheinmetall AG. He is currently Chairman of the Board of the industrial group Bilfinger SE. Eckhard Cordes is a partner in Cevian Capital and EMERAM Capital Partners. He holds a PhD and an MBA from the University of Hamburg. The Election Committee of AB Volvo comprises the Chairman of the Board and four representatives of the company’s largest owners, who together represent 22.4% of the shares and 46.7% of the votes. The members who represent the largest owners are Carl-Olof By, representative of AB Industrivärden, Lars Förberg, representative of Cevian Capital, Yngve Slyngstad, representative of Norges Bank Investment Management and Håkan Sandberg, representative of Svenska Handelsbanken, SHB Pension Fund, SHB Employee Fund, SHB Pensionskassa and Oktogonen. For further information, please contact: Carl-Olof By, Chairman of the Election Committee, telephone +46 (0)8-666 64 00. For more news from the Volvo Group, please visit http://www.volvogroup.com/globalnews. The Volvo Group is one of the world’s leading manufacturers of trucks, buses, construction equipment and marine and industrial engines. The Group also provides complete solutions for financing and service. The Volvo Group, which employs about 100,000 people, has production facilities in 19 countries and sells its products in more than 190 markets. In 2014 the Volvo Group’s sales amounted to about SEK 283 billion and is listed on Nasdaq Stockholm. For more information, please visit www.volvogroup.com or www.volvogroup.mobi if you are using your mobile phone. AB Volvo (publ) may be required to disclose the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 08.30 a.m February 25, 2015.

Holmen reduces carbon dioxide emissions by 45 per cent

The investment in a new recovery boiler at the paperboard mill in Iggesund has significantly reduced emissions of fossil carbon dioxide and the target is to become self-sufficient in heating and electricity. As a result of extensive energy investments the paperboard mill in Workington currently runs on biofuel and is self-sufficient in electricity and thermal energy. In addition, fossil-free electricity is distributed to the local community. Today, the manufacture of paperboard in the Holmen Group is virtually fossil-free. Major investments have been made at Hallsta Paper Mill to increase its energy efficiency, mainly through increased heat recovery from paper machines and pulp production. During 2014, emissions of fossil carbon dioxide decreased by around 70 per cent compared with 2013. At Braviken Paper Mill, oil consumption has decreased due to improvements in the operational strategy for the mill’s steam system, greater efficiency in the solid fuel boiler and increased steam recovery from the production of thermo-mechanical pulp. Together these measures have allowed Holmen to reduce emissions of fossil carbon dioxide by 45 per cent in 2014, from 123 to 67 kilos per tonne of paper and paperboard products produced, compared with 2013. In recent years Holmen has received several awards for its sustainability work and is included in the UN’s global stock index Global Compact 100 for companies that show a strong financial performance combined with sustainable operations. During 2014 Holmen also gained a place in the Carbon Disclosure Projects (CDP) list of 187 listed companies that are pioneers in the fight against the threat of climate change. In January 2015 Holmen was also named by CDP as one of the 121 best suppliers in the world as regards action against climate change. Lars Strömberg, Holmen’s director of sustainable and environmental affairs comments:“Our strategy of investing in fossil-free technology at the mills in Sweden and the UK has been crucial for our sustainability work and we are very satisfied with the results for 2014. Being recognised with awards and being included in the sustainability index is acknowledgement of our work. Our efforts on energy and climate issues also create trust, which strengthens our brand with regard to investors, customers and suppliers.” For further information, please contact:Ingela Carlsson, communications director, Holmen, tel. +46 (0)70-212 97 12

JustoCat - robotic therapy cat for people with dementia and intellectual disabilities

The functions of JustoCat makes it resemble a live cat. It breathes, purrs and meows. One advantage with the cat's fur is that it is washable and above all is removable and thus can meet hygiene requirements in an institution. JustoCat can provide peace, be soothing and be a tool for increased interaction and communication. It is a complement in the care of people with dementia and in the care of people with intellectual disabilities. Tests and research demonstrates positive results from the users, as well as patients / clients and care-givers. - The goal of JustoCat is to enrich the daily lives of people with dementia. It can provide increased psychological, physical and social well-being, says Lars Asplund, creator of JustoCat. A preliminary study made by the researcher Marcus Persson at Mälardalen University also shows the positive impact of the psychosocial work environment for health care personnel. JustoCat is now available on the European market, both for sale and through leasing, via the company Robyn Robotics AB operated by the two innovators / researchers at Mälardalen University, Lars Asplund and Christine Gustafsson. Several units have already been sold to a number of health and social care operators in Sweden and Europe. Robotdalen has participated in and contributed to the development of JustoCat. - JustoCat is a product that provides an improved quality of life, which is the core of Robotdalen’s focus on new technical solutions within the field of health robotics, says Erik Lundqvist, General Manager at Robotdalen. For further information, please contact Erik Lundqvist, General Manager at Robotdalen, email erik.lundqvist@robotdalen.se or phone +46 (0)21 10 70 26 or Lars Asplund, CEO at Robyn Robotics, email  lars.asplund@robynrobotics.se or phone +46 (0)705 41 46 68.

The rebirth of a legend - Jensen returns with limited edition Jensen GT

Almost 80 years since the Jensen name appeared on cars, the famous marque returns with the opportunity to order the first officially sanctioned model in 13 years. Marking the rebirth of the brand, the formation of the Jensen Group is the start of the next chapter in the Jensen story, following the collapse of the car manufacturer in 2002. Spearheaded by industry stalwart Tim Hearley, the return allows enthusiasts to purchase an officially sanctioned car, the Jensen GT. As the man responsible for the return of Jensen, and the force behind defending the Jensen trademark for almost four years, Tim Hearley, executive chairman of The Jensen Group, is delighted with the re-launch of the marque: “This represents the next chapter of Jensen and, as we look to the future, we want Jensen enthusiasts to help us celebrate as we unveil a completely new car and outline our plans for the future.” The Jensen Group is currently engaged on a project to launch Interceptor 2 in 2016, which may involve collaboration with an established automotive group. The Jensen GT will fill the gap between the last true Jensen, the Interceptor of 1976, and an all-new, state-of-the-art car due to be revealed in 2016. This new model, classed as Interceptor 2, will take design cues from the classic Interceptor and will advance the concept of the original grand tourer, to provide a thoroughly modern and exciting vehicle. Despite several companies claiming to be the spiritual home of Jensen, the Jensen GT is the first new car to legitimately bear a Jensen badge in the more than 13 years, since the demise of the S-V8 in 2001. This extremely limited edition will be built under an agreement between the Jensen Group and Jensen International Automotive (JIA), well known for their modified Interceptor R models. The Jensen GT will be available exclusively through JIA. ENDS Contacts For Jensen Group press information, please contact Torque: Matt Sanger       – 020 7952 1079 or msanger@torqueagencygroup.com Adam Forshaw – 020 7952 1082 or aforshaw@torqueagencygroup.com (aforshaw@torqueagencygroup.com%20) About The Jensen Group The Jensen Group licences, markets and uses the Jensen and Interceptor names for use within the automotive sector as well as other industries. The Jensen Group is currently engaged in a project to launch the new Interceptor 2 during 2016, which may involve collaboration with an established automotive group. www.jensengroup.co.uk

News release from Beijer Ref

The Swedish refrigeration wholesale group, Beijer Ref AB, is acquiring all the shares in the refrigeration wholesale company, RNA Engineering & Trading, which has its head office located in Kuala Lumpur, Malaysia. RNA Engineering & Trading was established in 1975. The company reports sales of approximately SEK 45M. RNA is the leading refrigeration wholesaler in Malaysia and includes Danfoss, Emerson and Thermal-Matic among its important brands. The Malaysian market for commercial refrigeration is estimated to be worth nearly SEK 480M, with stable growth in past years of around 10 per cent per annum. ”The acquisition complements our existing operation in the region and strengthens our presence outside Europe. This is fully in line with our strategy”, says Per Bertland, CEO of Beijer Ref. RNA Engineering & Trading is being acquired by Beijer Ref’s joint-venture company B Grimm in Thailand. The company will be integrated into Beijer Ref’s organisation and included in the company’s accounts from March 2015. The acquisition is expected to have a marginally positive effect of Beijer Ref’s net income in 2015. RNA Engineering & Trading’s management will continue to take an active part in the company. Malmö, 25 February 2015 Beijer Ref AB (publ) For further information, please contact: Per Bertland, CEO Telephone +46 40-35 89 00 Mobile +46 705-98 13 73 or Jonas Lindqvist, CFO Telephone +46 40-35 89 00 Mobile +46 705-90 89 04 BEIJER REF AB is a technology-oriented trading Group which, through added-value products, offers its customers competitive solutions within refrigeration and climate control. Beijer Ref is one of the largest refrigeration wholesalers in the world, and is represented in Belgium, Denmark, Estonia, Finland, France, Ireland, Italy, Latvia, Lithuania, Poland, Holland, Norway, Romania, Switzerland, Slovakia, Spain, United Kingdom, Sweden, the Czech Republic, Germany, Hungary, South Africa, Mozambique, Zambia, Botswana, Namibia, Malaysia and Thailand. www.beijerref.com

Nordic Nanovector ASA - Approved Listing Application

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF THE ANNOUNCEMENT Oslo, 25 February 2015: Reference is made to the stock exchange notice 29 January 2015, announcing that Nordic Nanovector ASA (“Nordic Nanovector” or the “Company”) has submitted an application for listing of its shares on the Oslo Stock Exchange. In a meeting held today, the board of directors of the Oslo Stock Exchange approved the Company’s listing application and resolved to admit the shares of the Company to listing on the Oslo Stock Exchange, subject to the Company publishing an approved prospectus prior to the first day of listing. The board of directors of Oslo Stock Exchange authorised the chief executive officer of Oslo Stock Exchange to fix the date of the first day of listing, which is to be no later than 10 April 2015. The first day of listing on the Oslo Stock Exchange is expected to be end of March 2015. ABG Sundal Collier and DNB Markets (a part of DNB Bank ASA) are acting as Joint Global Coordinators and ABG Sundal Collier, Carnegie and DNB Markets are acting as Joint Bookrunners in the contemplated IPO.Information:Luigi Costa, CEOCell:    (41) 79 124 8601  Fax:    (47) 22 58 00 07E-mail: lcosta@nordicnanovector.comTone Kvåle, CFOCell:    (47) 91 51 95 76Fax:    (47) 22 58 00 07E-mail: tkvale@nordicnanovector.comAbout Nordic NanovectorNordic Nanovector was established in 2009 and has its main office and laboratories in Oslo, Norway. The Company aspires to become a leading provider of Antibody-Radionuclide-Conjugate (“ARC”) clinical solutions, to address major unmet medical needs and to advance cancer care through its innovative therapy programs and patented technologies. The Company intends to directly commercialize its product candidates, by creating a differentiated and specific positioning, investing in cross-specialty collaboration and medical education. The Company is also committed to continue developing the ARC pipeline leveraging on its proprietary nanovector targeting technology.The Company’s lead product candidate, Betalutin™, is an Antibody-Radionuclide-Conjugate that aims to prolong the survival and improve the quality of life of patients who suffer from non-Hodgkin Lymphoma (“NHL”), a life-threatening blood cancer with a high unmet medical need. The product candidate is currently undergoing a Phase I/II clinical trial for treatment of relapsed NHL.Further information about the Company can be found at www.nordicnanovector.com. IMPORTANT INFORMATIONUnited StatesThese materials may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. These materials do not constitute an offer of securities for sale or a solicitation of an offer to purchase securities (the “Shares”) of Nordic Nanovector ASA (the “Company”) in the United States, Norway or any other jurisdiction. The Shares of the Company may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”). The Shares of the Company have not been, and will not be, registered under the U.S. Securities Act. Any sale in the United States of the securities mentioned in this communication will be made solely to “qualified institutional buyers” as defined in Rule 144A under the U.S. Securities Act. European Economic AreaAny offering of securities will be made by means of a prospectus to be published that may be obtained from the issuer or selling security holder, once published, and that will contain detailed information about the Company and its management, as well as financial statements. These materials are an advertisement and not a prospectus for the purposes of Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the “Prospectus Directive”). Investors should not subscribe for any securities referred to in these materials except on the basis of information contained in the prospectus. In any EEA Member State other than Norway (from the time the prospectus has been approved by the Financial Supervisory Authority of Norway, in its capacity as the competent authority in Norway, and published in accordance with the Prospectus Directive as implemented in Norway) that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at “qualified investors” in that Member State within the meaning of Article 2(1)(e) of the Prospectus Directive (“Qualified Investors”), i.e., only to investors to whom an offer of securities may be made without the requirement for the Company to publish a prospectus pursuant to Article 3 of the Prospectus Directive in such EEA Member State. United KingdomIn the United Kingdom, these materials are only being distributed to and are only directed at Qualified Investors who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”) or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) (all such persons together being referred to as “Relevant Persons”). These materials are directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. 

New Wave Group employs Joakim Sylmé

New Wave Group has recruited Joakim Sylmé as responsible for the Group's purchasing and trading within the product areas gifts and hard promotional articles with location in Shanghai, China. Joakim Sylmé, with over 25 years experience within corporate promo, has been active in both the dealer and wholesale segments. Over the past 13 years, his focus has been on international business development and Supply Chain Management in the Dutch wholesale company Xindao Shanghai Ltd. (Shanghai / China), where he, since 2006, also been the CEO. Joakim's responsibilities have been within the product areas for gifts and hard promotional articles. "I feel incredibly inspired to be back in the New Wave Group and as a step to further develop the group, I enthusiastically looking forward to adding my skills from China and share my experiences into new product areas. New Wave Group has a unique position in the market and a lot of confidence in their dealers. We will manage this confidence well by strengthening and expanding the range and increasing opportunities to do business together", says Joakim Sylmé. "I am very proud and happy that Joakim join us and he will mean a lot for our future development within the gifts and hard promotional articles" says Torsten Jansson, CEO. New Wave Group AB is listed on NASDAQ OMX Nordic Exchange in Stockholm. New Wave Group is a growth company that designs, acquires and develops brands and products in the corporate promo, sport, gifts and home furnishings sectors. For more information, please visit www.nwg.se. Göteborg, February 25, 2015 New Wave Group AB (publ) Torsten JanssonCEO & PresidentTel: +46 31 712 89 01

Planmed Verity® Extremity CT Scanner Added to Novation Contract with Merry-X-Ray

The Planmed Verity® extremity scanner is designed to find even the most subtle extremity fractures during the patient’s first visit to a clinic – the types of fractures that are often missed when using only 2D radiographs. The Planmed Verity extremity scanner provides fast pre- and postoperative 3D imaging at the point of care – enabling high resolution images with lower patient dose than full-body CTs. Unlike any other 3D imaging device, Planmed Verity also allows for weight-bearing imaging of the extremities. The mobile scanner adapts to different patient needs with anatomy-specific imaging programs, movements, and trays. Easily adjustable soft-surfaced gantry and motorized positioning trays support comfortable positions for various examination procedures. The adjustable user interface and efficient all-in-one workflow are also designed to maximize the operator’s soothing presence for the patient. The Planmed Verity CT scanner was also awarded Novation’s Innovative Technology designation following a review by Novation’s Imaging Council, which indicated the Planmed Verity CT scanner offered incremental benefit over other products available on the market. Olya Carter, RN and Senior Clinical Manager at Novation, said, “We are pleased that Novation-served hospital representatives recognized the unique benefits of the Planmed Verity CT system and awarded it the company’s Innovative Technology designation.” For further information, please contact:Mr Vesa Mattila, Managing Director, Planmed Oy                                                                                      Tel. +358 20 7795 301                                                                                                       vesa.mattila@planmed.com Planmed Oy and the Planmeca Group Planmed Oy develops, manufactures, and markets high technology imaging devices for mammography and orthopedic imaging. Planmed’s products are sold in more than 70 countries worldwide, with considerable market shares in Europe, Japan, and Oceania, as well as in North and Latin America. The company is headquartered in Helsinki, Finland.Planmed Oy is a part of Planmeca Group, which operates in the field of health care technology. The Group’s turnover is MEUR 740 (2014) with nearly 2,700 employees worldwide.www.planmed.com Merry X-Ray Corporation Merry X-Ray Corporation distributes X-ray equipment, accessories, and supplies throughout the United States. Merry X-Ray’s Service Department performs service, maintenance, and installation of conventional and digital x-ray equipment. Founded in 1958, Merry X-Ray Corporation has a reputation as the "Go To" distributor for all X-ray imaging needs. The company provides service to all 48 contiguous states, as well as Hawaii and Alaska, making it the largest distributor of X-ray equipment nationwide. Merry X-Ray Corporation represents and supports over 10,000 products. The company employs approximately 500 team members. www.merryxray.com

Saab Selects AEL Sistemas as a New Gripen Supplier in Brazil

The new avionics systems programme will run over four years and includes development, integration and production work to be performed in Porto Alegre. System integration work will be undertaken by Saab and Embraer.The WAD for Brazil’s Gripen NG aircraft is a single intelligent and full-redundant multi-purpose display system, full-colour, large-screen (19 x 8 in) with continuous image presentation and the state-of-the-art touch-screen controls capability. It is the primary source of all flight and mission information in the cockpit.AEL will also develop a new HUD for Brazil’s Gripen NG aircraft. The HUD provides essential flight and mission information to the pilot when looking ‘heads up’ out of the cockpit.“Incorporating these advanced products from AEL into Brazil’s Gripen NG further enhances the aircraft. This agreement also shows our continuing commitment to develop and produce the Gripen in close partnership with Brazilian industry,” says Ulf Nilsson, head of Saab business area Aeronautics.“We are proud of the opportunity to take part in the development process of Gripen NG and to be able to introduce the latest displays, computer and software technologies into a next generation fighter. I am sure it will further enhance the successful contribution of AEL to the Brazilian Military Forces,” says Sérgio Horta, President AEL.An extensive flight test campaign will be conducted in close co-operation with AEL at Saab’s site in Linköping, Sweden, to demonstrate and validate the new equipment.The transfer of technology contract with AEL will focus on further development of the human machine interface (HMI) for advanced fighters, along with workshops for avionics maintenance. Activity under this contract will commence in the second half of 2015 at Saab in Linköping and will include theoretical courses and on-the-job-training.For further information, please contact:Saab Press Centre, +46 (0)734 180 018,presscentre@saabgroup.comwww.saabgroup.comwww.saabgroup.com/YouTubeFollow us on twitter: @saabSaab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

YEAR-END REPORT VIGMED HOLDING AB JANUARY 1 – DECEMBER 31 2014

Financial information for the fourth quarter in brief · Net Sales for the fourth quarter amounted to kSEK 685 (0 SEK in 2013). · Operating profit in the fourth quarter for the Group amounted to MSEK -9.6 (MSEK -4.6). · Net income per weighted number of shares for the fourth quarter amounted to SEK -0.26 (SEK-0.12). · Cash flow from operating activities during the fourth quarter amounted to SEK -4.2 million (SEK -4.4 million). · Cash flow from investing activities during the fourth quarter amounted to MSEK -10.9 (MSEK -4.0). · Cash flow from financing activities during the fourth quarter amounted to MSEK 59.4 (MSEK -0.3). The positive cash flow from financing activities relates mainly to the rights issue of net MSEK 52.1. Financial information for the year in short · Net Sales for the year amounted to kSEK 1,124 (0 SEK during 2013). · Operating profit for the year for the Group amounted to MSEK -32.0 (MSEK -21.0). · Net income per weighted number of shares for the year amounted to SEK -0.85 (SEK-0.65). · Cash flow from operating activities during the year amounted to MSEK -20.9 (MSEK -23.3). · Cash flow from investing activities during the year amounted to MSEK -17.5 (MSEK -12.3). · Cash flow from financing activities amounted to MSEK 60.0 (MSEK 24.8). The financing relates mainly to the rights issue of MSEK 52.1. · Cash and cash equivalents at end of period amounted to MSEK 63.5 (MSEK 41.8). · The shareholders’ equity at the end of the period amounted to MSEK 73.8 (MSEK 53.4). The Board of Directors of Vigmed Holding AB For additional information please read the full Year-End Report

CTT SYSTEMS receives first airline order for A350-900 humidifiers

The airline has ordered humidifiers for flight deck and flight crew rest compartment to be installed in its first A350-900 aircraft. The airline has in total 12 A350-900 on order and is operating a fleet of Boeing 787s equipped with CTTs flight deck/crew rest humidifiers. The flight deck air is normally extremely dry as is the air in the crew rest compartments. By humidifying the air, work and rest conditions improve significantly. Not only will crew benefit from higher humidity levels during flights, but they will also recover faster during layovers and return flights. “CTT is pleased with this first A350-order and delighted that it is from a Boeing 787-customer reassuring our product humidifiers are sought after for the world’s two most advanced commercial aircraft,” says Peter Landquist, Vice President Sales & Marketing of CTT Systems. “The airline demand for flight deck/crew rest humidification is clearly defined and proven on the Boeing 787 aircraft. With this recent order, we are honoured to be the sole supplier for both the Airbus A380 and A350XWB”. About CTT SYSTEMS CTT’s Zonal Drying™ System is basic equipment on all Boeing 787 “Dreamliner” aircraft and the humidifiers are standard in all crew rest compartment fitted Dreamliner aircraft and optional for flight deck. The flight deck humidifier is optional on the A350XWB aircraft, the crew rest compartments humidifiers are optional on both A380/A350XWB and the Zonal Drying™ and Cair™ systems are optional on the A350XWB aircraft. Cair™ is the leading cabin humidification system maintaining the relative humidity above 20% without causing condensation. The cabin air in First Class is normally extremely dry (3-5%). Cair increases passengers wellbeing by reducing dry air related problems (e.g. fatigue, jet-lag, red eyes, dry skin, spread of virus diseases). The dual-purpose system increases humidity for greater comfort and the anti-condensation Zonal Drying™ System prevents condensation from actively humidifying the cabin air. Also visit: www.ctt.se For additional information: Torbjörn Johansson, President, CTT Systems AB.Tel. +46-155-205901 alt. mobile. +46-70-665 24 46, or E-mail: torbjorn.johansson@ctt.se Peter Landquist, VP Sales, Marketing & Customer Support CTT Systems AB.Tel. +46-155-205902 alt. mobile. +46-70-665 24 45, or E-mail peter.landquist@ctt.se                      This information is disclosed by CTT Systems AB in accordance with the Swedish Securities Markets Act, the Swedish Financial Instruments Trading Act, or the requirements stated in the listing agreements. The information was submitted for publication on February 25, 2015 at 13:45 (CET)

Allianz Foundation for North America Continues Support of Virginia Council on Economic Education (VCEE) to Prepare Students for Economic Success

The Allianz Foundation for North America (https://www.allianz.com/en/responsibility/foundation_north_america/afna.html) has awarded a continuing $25,000 grant to the Virginia Council on Economic Education (http://www.vcee.org/) (VCEE), a nonprofit organization providing K-12 economic and financial education through teacher training, classroom resources, and statewide advocacy.  This latest grant brings total Allianz Foundation funding of VCEE programs to $75,000 since 2013. VCEE and its affiliated university-based centers for economic education are the primary resource for Virginia’s K-12 teachers and school divisions seeking training and classroom resources for economic and financial education. Funds from the Allianz Foundation grant will be used to support the VCEE’s Virginia High School Economics and Personal Finance Initiative. “The Allianz Foundation is committed to empowering young people to shape a secure future, not least by developing their financial awareness and skills - to benefit themselves, the economy, and society as a whole,” said Christopher Worthley, Executive Director of the Allianz Foundation for North America.  “The Virginia Council on Economic Education provides training, resources and tools so that teachers are better prepared to help their students succeed in today’s economy.” “Virginia is a national leader in requiring students to earn full credit in economics and personal finance in order to graduate.  This requirement helps prepare students to be successful employees and entrepreneurs as well as informed citizens and voters,” said Daniel R. Mortensen, VCEE’s Executive Director. “This is truly a competitive advantage for Virginia and will help create a stronger economy for the future.  We appreciate the continued support of Allianz and the Allianz Foundation in this important effort.” As one of the world’s largest financial services companies, Allianz is committed to improving financial literacy. The company, with operations in over 70 countries, understands that economic knowledge and financial skills are critical for young people to thrive in today’s dynamic, global economy. Allianz and its philanthropic arm in the United States, the Allianz Foundation for North America, have chosen to recognize and support innovative programs like the Virginia High School Economics and Personal Finance Initiative which will be studied and replicated in other states, further improving financial education for all. #     #     # Allianz Foundation for North America The mission of the Allianz Foundation for North America is to empower young people to shape a secure future for themselves and for the communities in which they live. The Foundation is committed to creating sustainable social value by partnering with programs that help young people develop the skills, motivation, perspectives and opportunities they need to be successful, self-reliant and socially conscious members of society. Allianz  · Allianz is ranked 27th in the Forbes Global 2000 (2014) and is the 55th most valuable global brand (Interbrand, 2014). Allianz has 144,000 employees worldwide and 83 million customers in more than 70 countries. In 2013, Allianz had 110.8 billion euros in revenue and over 1,770 billion euros under management. Allianz entities in the U.S. include: · Allianz Global Assistance · Allianz Life · Allianz Global Investors · PIMCO · Fireman’s Fund · Euler Hermes · Allianz Global Corporate & Specialty Virginia Council on Economic Education For over forty years, the Virginia Council on Economic Education (VCEE) has been providing Virginia’s K-12 students with economic knowledge and financial skills needed to thrive in our dynamic economy. By partnering with teachers and school divisions, VCEE seeks to help students understand economic concepts and develop decision-making skills needed to be informed consumers, productive employees or innovative entrepreneurs, thoughtful investors, and reasoned voters. VCEE operates as a true public-private partnership by leveraging the collective intelligence, resources, and vibrant spirit of state government, local school divisions, universities, business leaders, and teachers. For further information contact: Daniel Durazo Allianz Global Assistance USA (http://www.allianztravelinsurance.com/) (804) 673-7175 Judi CrenshawVirginia Council on Economic Education (804) 827-7402 jwcrenshaw@vcu.edu

Owner of OnTheGo2 Predicts User Requirement Trend for Waterproof Camera Cases

Kim Santora founder of OnTheGo2 has predicted a user trend and adapted her products to a growing need.  Kim Santora has foreseen that users of the innovative GoPro camera will need to carry their equipment, sometimes over difficult terrain, and they will need a durable and robust case to protect it. More and more people are investing in the portable cameras and experimenting with them in day to day life. That means that GoPro owners want to use the camera more regularly, and take it to places that perhaps they would never before dare to take a piece of expensive photography equipment. The OnTheGo2 GoPro case (http://www.amazon.com/gp/product/B00KUZ3V9M) is made from water resistant premium carbon fiber, ensuring it can withstand rain, spillages or splashes from waterfalls or watersports. The double zippers work as an extra protective measure, protecting the expensive equipment from accidental water damage. It also has a variety of compartments for users to store vital camera accessories and other essentials on-the-go. Kim Santora, designer/inventor of the camera case says, “I spotted a gap in the market a while back now, and I think this product is at the forefront of GoPro camera cases. Waterproof, lightweight, practical and stylish, it really is everything a GoPro camera owner could ever need.” The rigid, outer shell of the camera case gives GoPro owners peace of mind when on-the-go with the camera. The OnTheGo2 GoPro case is set to become the latest must-have accessory for hikers, rock-climbers, water sports fans and adrenaline junkies all over the globe. For more information about the brand new GoPro case, or to buy it from Amazon, visit the product page: http://www.amazon.com/gp/product/B00KUZ3V9M

1 in 3 people over 55 not making educated financial decisions

The survey highlighted people’s misconceptions about certain products with: · 23.8% not understanding what an over 50s life insurance plan provides. · 11% of respondents wrongly believing that an over 50s life insurance policy guarantees to pay your funeral costs. · 32% unaware of the difference between a funeral plan and over 50s life insurance Commenting on the study, Ashley Shepherd, Managing Director at Over50choices.co.uk, the leading over 50s comparison site, said “People need to be better informed about their funeral planning options, as they could be buying a product that isn’t the most appropriate for their needs - and therefore perhaps not protecting their family in the way they had wished. “Both plans have an important role to play but worryingly nearly a third of people don’t know what this is. Whilst a funeral plan will guarantee your funeral director’s costs, an over 50s life insurance plan will only give you a cash sum to help with funeral costs; a pot of money that will be eroded by inflation over the years. “It’s easy for the consumer to be confused, particularly online where both types of plans are promoted under various ‘funeral plan’ terms. What is concerning is that families could be left with heartache and a financial burden that they could be paying for in years to come”. Ashley explains that: · the average cost of a funeral today is £3,590**, · in 20 years time with funeral inflation this could rise to over £11,000***. He cites an example of a 60 year old man who purchases over 50s life insurance with a cash sum of £5,000 today. Based on the figures above, if he dies aged 80, his family could be left with a £6,000 shortfall when arranging his funeral. Ashley summarises: “The final decision for some could be down to budget. With an over 50s life insurance plan typically starting from £8 a month, they are considerably cheaper than funeral plans. Though when the time comes to make a claim on the policy, it may not be fit for purpose if the customer thought all their funeral costs would be covered. “Whilst better consumer education is needed, the life insurance companies need to do their bit to make sure it’s crystal clear that a policy will meet a customer’s expectations.” Ends *Google Survey carried out on behalf of Over50choices.co.uk, February 2015 ** SunLifeDirect report (https://www.sunlifedirect.co.uk/WorkArea/DownloadAsset.aspx?id=19327353063) ***Over50choices funeral calculator (http://www.over50choices.co.uk/funeral-planning/paying-for-a-funeral/funeral-calculator)

PA Resources receives approval for deferred interest payments

The bondholders in PA Resources’ NOK and SEK denominated bonds, have at the bondholders meeting and by the written procedure respectively, approved PA Resources’ proposal announced on 10 February 2015 of, inter alia, deferred interest payments. The decision to approve the proposal obtained 99.86% of the votes in the written procedure for the SEK bonds and was unanimous in the bondholders meeting for the NOK bond. In summary, the approval means that the originally scheduled payment dates in October 2014 under the bonds have been deferred to 31 March 2015 and that, consequently, interest payments owed to PA Resources’ largest creditor and shareholder, the Gunvor Group, under credit facilities with them, are deferred until 31 March 2015. Notwithstanding the interest payment deferrals, a majority of the bondholders, and the Gunvor Group, are entitled under the respective agreements to give notice to bring the relevant interest payment dates forward to the third business day following the date on which the notice is given. Stockholm, 26 February 2015 PA Resources AB (publ) For queries, please contact: Tomas HedströmCFOPA Resources ABTel: +46 (0)8 545 211 50E-mail: ir@paresources.se PA Resources AB (publ) is an international oil and gas group which conducts exploration, development and production of oil and gas assets. The Group operates in Tunisia, Republic of Congo (Brazzaville), Equatorial Guinea, United Kingdom, Denmark, Netherlands and Germany. PA Resources is producing oil in West Africa and North Africa. The parent company is located in Stockholm, Sweden. PA Resources’ net sales amounted to SEK 1,049 million in 2013. The share is listed on the NASDAQ OMX in Stockholm, Sweden. For additional information, please visit www.paresources.se. The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07.45 a.m. CET on 26 February 2015.

Bariatric surgery affects risk of pregnancy complications

Pregnant women with obesity run a higher risk of developing complications during pregnancy and risks of fetal/infant complications are also higher. There has been a sharp rise in the number of women becoming pregnant after bariatric surgery; in 2013 almost 8,000 such operations were performed in Sweden, 80 per cent of which were on women. “The effects of bariatric surgery on health outcomes such as diabetes and cardiovascular disease have been studied, but less is known about the effects on pregnancy and perinatal outcomes,” says the study’s lead author, Kari Johansson, PhD, from the Department of Medicine in Solna. “Therefore we wanted to investigate if the surgery influenced in any way the risk of gestational diabetes, preterm birth, stillbirth, if the baby was small or large for its gestational age, congenital malformations and neonatal death.” Using data from nationwide Swedish health registries, the researchers identified 596 pregnancies to women who had given birth after bariatric surgery between 2006 and 2011. These pregnancies were then compared with 2,356 pregnancies to women who had not been operated upon but who had the same body mass index (BMI, weight divided by height squared) as the first group prior to surgery. What researchers found was that the women who had undergone surgery were much less likely to develop gestational diabetes – 2% compared to 7% – and give birth to large babies. Just over 22% of women in the comparison group had babies that were large for gestational age, and barely 9% of the operated women. On the other hand, the operated women were twice as likely to give birth to babies who were small for gestational age, and the pregnancies were also of shorter duration. “Since bariatric surgery followed by pregnancy has both positive and negative effects, these women, when expecting, should be regarded as risk pregnancies,” says Dr Johansson. “They ought to be given special care from the maternal health services, such as extra ultrasound scans to monitor fetal growth, detailed dietary advice that includes checking the intake of the necessary post-surgery supplements.” The study was financed by the Swedish Research Council, The Obesity Society, Karolinska Institutet and the Stockholm County Council.     Publication: “Outcomes of Pregnancy in Women with Prior Bariatric Surgery (http://www.nejm.org/doi/full/10.1056/NEJMoa1405789)”, Kari Johansson, Sven Cnattingius, Ingmar Näslund, Nathalie Roos, Ylva Trolle-Lagerros, Fredrik Granath, Olof Stephansson, & Martin Neovius, New England Journal of Medicine (http://www.nejm.org/) online 26th February 2015.

Clavister Secures Mexican Universities Wi-Fi networks

Clavister provide a purpose built solution comprising its next generation X8 and W3 firewalls and its cOS core security software to deliver a secure, reliable Wi-Fi network with extensive coverage and supporting traffic management and tracking. The solution handles multiple access points and a high volume of concurrent users, providing robust security to the entire coverage area and enforces the Universities functionalities such as web filtering and tracking policies together with applications’ bandwidth management. The reliability of the solution with minimum downtime was essential in the decision process which Clavister solution fulfilled. Main features of the deployment include firewall, VPN, application control, policy and bandwidth enforcement, DHCP, web filtering and prevention of application-based vulnerabilities. Jim Carlsson, CEO of Clavister, said: “Working with Ericsson Mexico and Telmex we have delivered a large and secure, high-performance reliable and scalable Wi-Fi network to both the Universities and their students. Our solution enabled the University to ensure that students can securely access its network from a wide variety of locations, delivering an enhanced student experience, and maximising availability of resources.  The management level of the network will enable them to overcome the challenges of managing data in a variety of public locations while also enforcing its network policies to users.” In addition to the secure Wi-Fi network the Universities also wanted to be able to monitor network usage, including websites accessed, traffic generated and capabilities to prioritise bandwidth linked to applications to guarantee, prioritize and limit bandwidth based on applications related to authentication credentials.  The Clavister solution was selected following testing on a number of solutions in which Clavister impressed with its scalability and levels of traffic it could manage. Unlike other solutions Clavister’s could support thousands of users logging in simultaneously and demonstrating the capacity for extremely high volumes of network activity. In addition to being able to identify and track all users on the network via its external built in DHCP server the functionality delivered constant uptime during peak hours. In 2015 Clavister has also started work on a number of projects to deliver secure Wi-Fi networks including the Brazil “Smart Cities” initiative, with a focus on securing wireless networks at up to 1600 locations in the country and with the Swedish Hockey League to provide a secure platform to offer fans value-added in stadium services. 

PA Resources’ Year-end Report 2014

FULL YEAR · Group revenue totalled SEK 603 million (1,049) · EBITDA was SEK -480 million (-494) · Profit after tax was SEK -2,957 million (-1,219) · Earnings per share were SEK -26.13 (-21.54) · The Board of Directors proposes to the Annual General Meeting that no dividend be paid for the 2014 financial year. FOURTH QUARTER · Group revenue totalled SEK 88 million (193) · EBITDA was SEK -808 million (74) · Profit after tax was SEK -2,745 million (-402) · Earnings per share were SEK -24.26 (-3.55) +-----------------------------+|KEY EVENTS DURING THE QUARTER|+-----------------------------+ · Impairment charges resulted in a net effect of SEK -1,820 million recorded in profit for the period. The corresponding amount in equity was SEK -2,073 million. · Agreement to divest PA Resources’ 30 percent interest in Netherlands offshore Blocks Q7 and Q10a to Tulip Oil. · PA Resources awarded 25 percent of Blocks 22/18c and 22/19d in UK 28th Round containing the large Ekland prospect. · The farm out agreement for the transfer of 70 percent interest in each of the Didon field and the Zarat Permit to EnQuest has been terminated. PA Resources accounts for the termination as a one-off item in the fourth quarter, with a total net profit impact of SEK -826 million. SUBSEQUENT EVENTS · Lenders agreed to defer the interest payments due in February 2015 to 31 March 2015. · Successful Lille John appraisal well and sidetrack. · PA Resources awarded 33 percent in Block 21/24b in UK 28th Round containing the West Teal discovery. · PA Resources postponed release of the annual report until 29 April 2015 and the AGM as well as publication of the Q1 report until 29 May 2015. · PA Resources AB’s board of directors has resolved to convene an extraordinary general meeting of shareholders to be held Friday 27 February 2015 to determine whether or not the company should go into liquidation FINANCIAL KEY RATIOS Oct-Dec Jan-Dec 2014 2013 2014 2013Average production, barrels/day 2,900 3,600 3,100 5,000Revenue, SEK million 88 193 603 1,049EBITDA, SEK million -808 74 -480 -494EBITDA margin, % -914% 38% -80% -47%Operating profit, SEK million -2,856 -296 -2,667 -1,234Profit for the period, SEK million -2,745 -402 -2,957 -1,219Earnings per share after dilution, SEK -24.26 -3.55 -26.13 -21.54 For the complete report, see attached file. Stockholm, 26 February 2015PA Resources AB (publ) For queries, please contact:Tomas Hedström, CFO+46 8 545 211 50 Mark McAllister, President and CEO+46 8 545 211 50 ir@paresources.se Webcast conference call PA Resources' results for the fourth quarter of 2014 will be presented on 26 February 2015 at 09 a.m. (CET) via a webcast conference call. To participate, use the following link: Link to webcast: http://edge.media-server.com/m/p/g3ky9ait To participate via phone, please call:Sweden: + 46 8 505 564 74UK: +44 203 364 5374US: +1 855 753 2230 PA Resources AB (publ) is an international oil and gas group which conducts exploration, development and production of oil and gas assets. The Group operates in Tunisia, Republic of Congo (Brazzaville), Equatorial Guinea, United Kingdom, Denmark, Netherlands and Germany. PA Resources is producing oil in West Africa and North Africa. The parent company is located in Stockholm, Sweden. PA Resources’ net sales amounted to SEK 1,049 million in 2013. The share is listed on the NASDAQ OMX in Stockholm, Sweden. For additional information, please visit www.paresources.se. The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 08:00 am CET on 26 February 2015.

Interim financial report for the 12 month period ending December 31, 2014,   and for the quarter October – December 2014

Highlights during the quarter October – December 2014 · Nickel Mountain Group AB (“NMG”) held an Extraordinary General Meeting (“EGM”) on October 10, 2014 during which a new Board of Directors was appointed and a fully underwritten rights issue was approved. · The rights issue amounted to about 68 million NOK, and the terms of the issue were 3 new shares for 1 existing share on the record day. The issue price was 1 NOK per share. The rights issue was fully underwritten and was fully subscribed to in November 2014. · During the autumn of 2014, the first statements of defence were received from the defendants in the civil court case initiated by NMG against its former board members. A ruling by the Stockholm District Court is expected no earlier than year-end 2015, if not into 2016. · The financial position and liquidity situation of the group, following the recently completed rights issue, can now be considered satisfactory for the first time in two years. · In October 2014, the Supreme Administrative Court issued a positive ruling, from NMG’s point of view, in terms of the granted exploitation concessions for the Rönnbäcken Nickel Project (“RNP”). · Another EGM of NMG was convened on December 17, 2014 whereby PricewaterhouseCoopers (“PwC”) were elected as the new auditor of the Parent Company and of the Group. Financial results for the 12-month period 2014 and for the quarter October – December 2014 · The net result after tax for the 12-month period January – December 2014 amounted to MSEK –16.0 (MSEK –110.2). This corresponds to earnings per share (EPS) of SEK –0.54 (SEK –6.06). · The sale of former subsidiary IGE Diamond in June 2014 has positively affected the net result for the report period by approximately MSEK +2. · The total comprehensive loss for the full 12-month period of 2014 was MSEK –17.1 (MSEK –117.0). · The net result after tax for the October – December quarter of 2014 amounted to MSEK –4.2 (MSEK –20.1). This corresponds to earnings per share (EPS) of SEK –0.08 (SEK –1.11). · The total comprehensive loss for the quarter October - December 2014 was MSEK –5.3 (MSEK –20.8).

Alfa Laval wins SEK 55 million power order in the Middle East

The Alfa Laval compact heat exchangers will be used for cooling duties in an IGCC power plant. IGCC is a technology where coal and other carbon-based fuels are turned into synthesis gas, which is subsequently used to produce steam for power generation. “We are happy to announce yet another large energy-related order and this time from the demanding power industry,” says Lars Renström, President and CEO of the Alfa Laval Group. Did you know that… once completed, this will be one of the largest gasifier-based power facilities in the world? About Alfa Laval                                                                                                         Alfa Laval is a leading global provider of specialized products and engineering solutions based on its key technologies of heat transfer, separation and fluid handling. The company’s equipment, systems and services are dedicated to assisting customers in optimizing the performance of their processes. The solutions help them to heat, cool, separate and transport products in industries that produce food and beverages, chemicals and petrochemicals, pharmaceuticals, starch, sugar and ethanol. Alfa Laval’s products are also used in power plants, aboard ships, oil and gas exploration, in the mechanical engineering industry, in the mining industry and for wastewater treatment, as well as for comfort climate and refrigeration applications. Alfa Laval’s worldwide organization works closely with customers in nearly 100 countries to help them stay ahead in the global arena. Alfa Laval is listed on Nasdaq OMX, and, in 2014, posted annual sales of about SEK 35.1 billion (approx. 3.85 billion Euros). The company has about 18 000 employees. www.alfalaval.com For more information please contact:Peter TorstenssonSenior Vice President, CommunicationsAlfa LavalTel: + 46 46 36 72 31Mobile: +46 709 33 72 31Gabriella GrotteInvestor Relations ManagerAlfa LavalTel: +46 46 36 74 82Mobile: +46 709 78 74 82

Year-end report, 2014 Rabbalshede Kraft AB (publ)

2014 fiscal year · Production from the Group’s wind farms during January-December amounted to 314,665 MWh (189,431).   · Net sales totaled KSEK 146,161 (104,694). · EBITDA amounted to KSEK 81,270 (77,821). · EBIT was KSEK 14,325 (38,027). · The average sales price for wind power production amounted to SEK 497/MWh (560), of which electricity was SEK 315/MWh (351), electricity certificates and guarantees of origin were SEK 182/MWh (211). · Depreciation/amortization totaled KSEK 66,945 (39,794). Impairment losses on projects totaled KSEK 12,317. Impairment losses were incurred on the Årjäng NO and Ljungskile Hoven projects that had not received permits, and by other projects that were discontinued or pending due to unfavorable conditions. · The Company posted a loss after tax of KSEK 25,083 (profit: 117). · All 33 wind turbines in the Skaveröd/Gurseröd, Årjäng NV and Årjäng SV wind farms are in production. The wind farms were put into commercial operation from December 2014. The wind farms are expected to produce 289,400 MWh/year, which will increase Rabbalshede Kraft’s production capacity by 130 percent. · Rabbalshede Kraft was granted an environmental permit for the Årjäng NV II wind farm comprising up to eight wind turbines (28 MW). The wind farm gained legal effect in July 2014. · Rabbalshede Kraft was granted an environmental permit for the Lyrestad wind farm comprising up to eight wind turbines (25 MW). The wind farm gained legal effect in January 2014. · The Board of Rabbalshede Kraft decided to start trading in the Company’s share on the Alternativa equities market on the Alternativa Lista. · The Annual General Meeting for the 2013 fiscal year was held on April 25, 2014, in Gothenburg, Sweden. · The Company employed Lars Jacobsson as its new Operational and Maintenance Manager. Lars assumed his position in April 2014 and is now part of the Company’s management.

Fine Art Prints Dealer Helps Collectors Secure Rare and Collectable Prints and Editions

Gracing walls with fine art is made markedly easier thanks to a London based platform that allows browsers to source and purchase limited edition fine art prints direct from leading galleries across the globe. Encompassing works from historic greats and modern masters alike, Printed Editions (http://www.printed-editions.com/) is an invaluable online resource for lovers of fine art. Launched in 2010, Printed Editions was borne from a desire to fill a gap in the market. While other limited edition print retailers did exist, none offered buyers the reassurance of dealing directly with galleries.  Michael Lieberman, Printed Editions founder said, “At the heart of Printed Editions is a desire to inspire collectors to purchase fine prints directly from leading galleries and publishers including New York's Gemini G.E.L., London's Sims Reed Gallery, Johannesburg's The White House Gallery, Beverly Hills' Revolver Gallery and Cologne's Galerie Boisserée. I love art and through this service I hope to share some of the world’s most beautiful masterpieces with collectors from across the globe.” The site is endorsed by 170 leading galleries from around the world, including New York’s Lower East Side Printshop, Long Island’s VanDeb Editions, Illinois’ Manneken Press and Colorado’s Oehme Graphics. Unlike other online art dealers Printed Editions also allows buyers to deal directly with galleries. This gives clients the complete peace of mind that they’re investing in 100% authentic prints sourced directly from the showcasing gallery. Armed with professional experience in the art sector, the in-house team of Printed Editions curators has cherry picked a collection of over 28,000 artworks from 2400 artists. The selection includes a diverse range of works from throughout history. From Renaissance period painters such as Rembrandt and Dürer, modern masters such as Picasso, Matisse, Chagall and Miro and contemporary pioneers such as Warhol, Lichtenstein, Hockney, Hirst and Banksy, Printed Editions is continually updating its collection with new prints sourced from a myriad of global galleries. Latest editions include Wayne Thiebaud’s ‘Gumball Machine’ from Miami’s Robert Fontaine Gallery, prints from Bert Stern’s ‘Marilyn Monroe: The Last Sitting Portfolio’ on display at New York’s RoGallery and Second Etching' by Wassily Kandinsky from London's Gilden's Arts Gallery. From its London headquarters Printed Editions sources limited edition prints, creates new gallery contacts and uploads available collections to the website. It also publishes regular blogs and newsletters which inform and educate collectors about the world of fine prints. From private collectors to professional retailers, Printed Editions has helped a global portfolio of clients secure premium quality fine art prints. Paul Stolper of London’s Paul Stolper Gallery said, “Printed Editions is a perfect showcase for us to highlight the prints that we publish.  It gives us a truly international reach that we not otherwise have, with new leads and enquiries received frequently.  The site is professional run, with constant and regular feedback, updates and prompts to continually improve performance. To find out more about Printed Editions and browse the entire collection of limited edition fine art prints, visit the website at: http://www.printed-editions.com/ Facebook: https://www.facebook.com/printededitions Twitter: https://twitter.com/printededitions Pinterest: https://www.pinterest.com/printededitions/

St David’s Day launch of Welsh Slate Aged Cavern Cheddar in Welsh stores

The new Cheddar, packed in the Creameries’ Dragon brand, has been developed in partnership with Llechwedd Slates Caverns. The cheese adopts a very traditional maturing method transported from the creameries’ Chwilog base to the Slate Cavern in Blaenau Ffestiniog and left to mature 500 feet underground. This maturation process, believed to be in the steepest mining maturation caverns, adds unique characteristics to the cheese; a firmer body and depth of flavour with rich savoury notes. To celebrate the launch of this authentic Welsh cheese and to coincide with St David’s Day, a cheese tasting weekend has been arranged at Llechwedd Slate Caverns on 28thFebruary and 1stMarch. The cheese is presented in a 200g pack under South Caernarfon Creameries’ own Dragon brand and is available to buy at local Welsh retailers.  Alan Wyn-Jones, Managing Director at South Caernarfon Creameries said “We have deliberately launched our Dragon Welsh Slate Aged Cavern Cheddar to coincide with St David’s Day. The process used in that the cheese is made from Welsh milk produced by our member farmers and left to mature deep in the mine at Blaenau Ffestiniog really highlights our Welsh heritage. St David’s Day seemed the perfect time to launch into Welsh stores and we hope that local people enjoy the Slate Aged Cavern Cheddar as it really has a distinct, mature flavour and a fabulous eating quality.” Ends

Recipharm presents its seventh International Environmental Award winner

Recipharm AB is today pleased to announce that its seventh International Environmental Award has been awarded to Dr Ettore Zuccato, head of the Laboratory of Food Toxicology, Department of Environmental Health Sciences at Mario Negri Institute for Pharmacological Research (Milan, Italy), in recognition of his longstanding work as an outstanding scientist, resulting in identification, quantification and monitoring levels of environmental contamination from pharmaceuticals. The purpose of the Recipharm International Environmental Award is to encourage and inspire best practice and innovation in order to promote good examples and to encourage environmental dialog within the pharmaceutical industry. The prize is awarded annually by Recipharm to the best environmental performance or environmental best practice and innovation by the academic community or pharmaceutical industry. Since Recipharm was founded in 1995, its commitment to environmental best practice has been a pivotal corporate mission. Dr Ettore Zuccato is internationally recognized as a leading scientist in the field of emerging environmental contaminants, with a specialist focus on pharmaceuticals and illicit drugs in surface waters. He has conducted pioneering research, together with other prominent scientists, on quantifying the occurrence of pharmaceuticals in the Italian aquatic environment, with the study results published in “The Lancet”, fuelling global concern about the potential environmental impact that pharmaceuticals can have. His group carried out multiple studies in waste water including identifying pharmaceutical pollutants prevalent in Northern Italy, and validating an analytical method that simultaneously determines pharmaceuticals of various therapeutic categories present in waste water. Furthermore, he initiated research into the presence of pharmaceuticals and their metabolites in Italian rivers, sewage treatment plants and drinking water samples,   characterising contamination and assessing related risks. Lars Backsell, Chairman of the board of Recipharm, commented: “Recipharm is deeply honoured to award this accolade to Dr Ettore Zuccato. Indeed, he is one the foremost authorities and leaders in the field of environmental contamination by pharmaceuticals. His authoritative research, which has been published extensively across world leading scientific journals, has provided a comprehensive view in this critical subject area.” He continued: “Moreover, one important focus of his research is the need for proper evaluation of the multiple possibilities offered by new technologies to improve pharmaceuticals to mitigate the adverse environmental consequences of widespread environmental contamination.” Commenting on winning the award, Dr Ettore Zuccato remarked: “I take great pride in being granted this award from Recipharm. I, together with other scientific experts and researchers, have devoted long years of research into harm caused to the environment and to drawing attention to the contamination concerned, how it can be best identified, assessed and monitored and how improvements can be made to reduce the levels.” He added: “ I look forward to continuing my studies in the certain knowledge that prominent organisations in the pharma industry, like Recipharm are taking an active interest in environmental contamination, and furthering the drive to heighten awareness and change matters for the better, through this type of accolade.” Contact information Lars Backsell, Recipharm Chairman of the Board, Tel: +46 8 602 52 00, Dr Ettore Zuccato, E-mail Ettore.Zuccato@marionegri.it , Tel. +39 02 3901 4544 For media enquiries, please contact Tristan Jervis or Alex Heeley at De Facto Communications on: E-mail: t.jervis@defacto.com  (t.jervis@defacto.com%20)or a.heeley@defacto.com Tel: +44 (0) 207 861 3019/3043 About Recipharm Recipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry employing some 2,200 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material including API and pharmaceutical product development. Recipharm manufactures more than 400 different products to customers ranging from Big Pharma to smaller research- and development companies. Recipharm’s turnover is approximately SEK 3.3 billion and the Company operates development and manufacturing facilities in Sweden, France, the UK, Germany, Spain, Italy and Portugal and is headquartered in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm. For more information on Recipharm and our services, please visit www.recipharm.com      

Cortendo to Present at Upcoming Investor Conferences

February 26, 2015 – Göteborg, Sweden and Radnor, Penn., USA – Cortendo AB (http://www.cortendo.com) [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, today announced President and CEO Matthew Pauls will present corporate updates at three investor conferences in March:  Cowen and Company 35th Annual Health Care Conference (http://www.cowen.com/conferences/upcoming-conferences/)Presentation: March 2, 2015 at 3:30 p.m. EST in the St. Botolph roomLocation: The Boston Marriott Copley Place, Boston, Mass. 27th Annual ROTH Conference (http://www.roth.com/main/page.aspx?pageid=7207)Presentation: March 10, 2015 at 8:30 a.m. PST in Salon 2Location: The Ritz Carlton, Dana Point, CA 22nd Annual Future Leaders in the Biotech Industry Conference (http://www.biocentury.com/conferences/futureleaders/dates)Presentation: March 20, 2015 at 9:00 a.m. EST in Room 508Location: Millennium Broadway Hotel and Conference Center, New York City, NY About Cortendo ABCortendo AB is a global biopharmaceutical company incorporated in Sweden and based in the United States. The Company’s strategic focus is to be the global leader in commercializing innovative medicines for orphan endocrine disorders. Cortendo is leading the way in the field of cortisol inhibition through the investigational drug, COR-003 (levoketoconazole), currently being studied in the global Phase 3 SONICS trial for the treatment of Cushing’s syndrome. COR-003 (levoketoconazole) has received orphan designation from both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). The Company’s intent is to independently commercialize its Orphan/Endocrine assets in key global markets and partner non-strategic product opportunities, such as diabetes, at relevant development stages. Risk and UncertaintyThe development of pharmaceuticals carries significant risk. Failure may occur at any stage during development and commercialization due to safety or clinical efficacy issues. Delays may occur due to requirements from regulatory authorities, difficulties in recruiting patients into clinical trials due to physician or patient preferences or competing products, not anticipated by the Company. There is no assurance that Cortendo will receive marketing and regulatory approvals necessary to commercialize or produce COR-003 (levoketoconazole) or other products. Regulatory approvals may be denied, delayed, limited or revoked. The commercial success of COR-003 (levoketoconazole), if approved in a territory, cannot be predicted with certainty. In addition, Cortendo may face the risk of interrupted supply of COR-003 for clinical or commercial use from the subcontractors Cortendo has contracted. Cortendo Forward-Looking StatementsThis press release contains forward-looking statements concerning Cortendo that involve a number of risks and uncertainties. All statements other than statements of historical facts included in this press release, including, without limitation, statements regarding the Company's future financial position, strategy, anticipated investments, costs and results, plans, projects to enhance efficiency, outcomes of products development, future capital expenditures, liquidity requirements and objectives of management for future operations, may be deemed to be forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements or industry results to be materially different from those contemplated, projected, forecasted, estimated or budgeted, whether expressed or implied, by these forward-looking statements. Given these risks and uncertainties, investors should not place any undue reliance on forward-looking statements as a prediction of actual results. None of these forward-looking statements constitutes a guarantee of the future occurrence of such facts and data or of actual results.  These statements are based on data, assumptions and estimates that the Company believes are reasonable. The forward-looking statements contained in this document are made only as of the date hereof. The Company expressly disclaims any obligation or undertaking to release publicly any updates of any forward-looking statements contained in this press release to reflect any change in its actual results, assumptions, expectations or any change in events, factors, conditions or circumstances on which any forward-looking statement contained in this press release is based. ### Corporate:Alexander LindströmChief Financial Officer, Cortendo AB+1 610-254-9200alindstrom@cortendo.comInvestors and Media:LaVoieHealthScienceDonna LaVoie and David Connolly+1 617-374-8800dlavoie@lavoiehealthscience.comdconnolly@lavoiehealthscience.com Sweden:Box 47SE-433 21 PartilleTel. / Fax. +46 (0)31-263010USA:555 East Lancaster Ave.Suite 510Radnor, PA 19087Tel. +1 610-254-9200Fax. +1 610-254-8005

Trigon Agri A/S announces that the bondholders have approved the extension of the maturity of its SEK 350 million bond

Trigon Agri A/S (the ‘Company’) today held the bondholder meeting of its SEK 350 million bond issue, where the bondholders approved the extension of the maturity of its SEK 350 million bond until August 31, 2017 on the terms disclosed earlier in the release announcing the bondholder meeting. At the meeting and the written procedure, bondholders representing 51.64% of the outstanding nominal amount unanimously approved the proposed amendments. The amendments entered into force immediately and the amended and restated terms and conditions can be found on the following web-link: www.corpnordic.com. Trigon Agri Chairman of the Board Joakim Helenius comments: “We are pleased to have received the support of our bondholders in today’s vote. The Company is showing strong operational results and cash flow despite the challenging regional conditions and low soft commodity prices, and now that we are no longer under immediate pressure from the maturing bonds we will return to implementing our previously announced strategy ” For further information please contact: Mr. Ülo Adamson, President and CEO of Trigon Agri A/S, Tel: +372 66 79200, E-mail: mail@trigonagri.com About Trigon Agri Trigon Agri is a leading integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Trigon Agri’s shares are traded on the main market of NASDAQ OMX Stockholm. Trigon Agri is managed under a management agreement by Trigon Capital, a leading Central and Eastern European operational management firm with around USD 1 billion of assets under management. For subscription to Company Announcements please contact us: mail@trigonagri.com.If you do not want to receive Trigon Agri press releases automatically in the future please send an e-mail to the following address: unsubscribe@trigonagri.com (mail@trigonagri.com).

Notice to Annual General Meeting

Notice is given to the shareholders of Finnair Plc to the Annual General Meeting to be held on Wednesday 25 March 2015 at 4 p.m. (EET) at Messukeskus Helsinki, Messuaukio 1, Conference Centre entrance. The doors will be opened and reception of persons who have registered for the Meeting will commence at 3 p.m. (EET). Coffee will be served prior to the Meeting. A. MATTERS ON THE AGENDA OF THE GENERAL MEETING At the General Meeting, the following matters will be considered: 1. Opening of the Meeting 2. Calling the Meeting to order 3. Election of persons to scrutinise the minutes and to supervise the counting of votes 4. Recording the legality of the Meeting 5. Recording the attendance at the Meeting and adoption of the list of votes 6. Presentation of the annual accounts including the consolidated annual accounts, the report of the Board of Directors and the auditor’s report for the year 2014. - Review by the Chief Executive Officer 7. Adoption of the annual accounts including the consolidated annual accounts 8. Resolution on the use of the profit shown on the balance sheet and the payment of dividend The Board of Directors proposes to the General Meeting that no dividend is paid based on the balance sheet to be adopted for the year 2014. 9. Resolution on the discharge of the members of the Board of Directors and the CEO from liability 10. Resolution on the remuneration of the members of the Board of Directors The Shareholders' Nomination Board proposes to the General Meeting that the annual remunerations of the members of the Board of Directors would be the following: -   Chairperson 61,200 euros per year; -   Vice Chairperson 32,400 euros per year; -   Chairpersons of the Audit Committee and Compensation and Nomination Committee 32,400 euros per year, where these individuals are neither the Chairperson nor the Vice Chairperson of the Board; and -   other members 30,000 euros per year. The Nomination Board further proposes to the General Meeting that each member’s fee for a meeting of the Board of Directors or its Committee would be 600 euros when the meeting takes place in the member’s country of residence and 2,400 euros for other meetings. For telephone meetings, the fee would be 600 euros. The Board members would be entitled to reimbursement of reasonable travel and representation expenses in accordance with the company’s general expenses policy. The Nomination Board also proposes to the General Meeting that Board members and their spouses would be entitled to discounted travel on the company’s flights in accordance with the company’s discount ticket policy regarding the Board of Directors. Under the current policy, the Directors and their spouses would be entitled to 4 return or 8 one-way tickets on Finnair flights per calendar year in Economy or Business Class. The fare of these tickets is zero, exclusive of any airport taxes, fees and charges, which are payable by the Directors. These tickets constitute taxable income in Finland. 11. Resolution on the number of members of the Board of Directors The Shareholders' Nomination Board proposes to the General Meeting that the number of members of the Board of Directors would be confirmed as seven. 12. Election of the Chairman and other members of the Board of Directors The Shareholders' Nomination Board proposes to the General Meeting that present members of the Board of Directors Maija-Liisa Friman, Klaus W. Heinemann, Jussi Itävuori, Harri Kerminen, Gunvor Kronman, Jaana Tuominen and Nigel Turner be re-elected, and that Klaus W. Heinemann be re-elected as the Chairman of the Board. All candidates have given their consent to the position. The biographical details of the proposed board members can be found on the company’s website at http://www.finnairgroup.com/group/group_4.html. 13. Resolution on the remuneration of the auditor In accordance with the Audit Committee’s recommendation, the Board of Directors proposes that the auditors’ fees be paid according to the auditors’ reasonable invoice. 14. Election of the auditor In accordance with the Audit Committee’s recommendation, the Board of Directors proposes that Authorised Public Accountants PricewaterhouseCoopers Oy, which has announced that APA Mikko Nieminen would be acting as the principal auditor, be elected as the auditor of the company for the term of office ending at the end of the next Annual General Meeting. 15. Authorising the Board of Directors to decide on the repurchase and/or on the acceptance as pledge of own shares The Board of Directors proposes that the Annual General Meeting would authorise the Board of Directors to decide on the repurchase and/or on the acceptance as pledge of the company's own shares. The amount of own shares to be repurchased and/or accepted as pledge shall not exceed 5,000,000 shares, which corresponds to approximately 3.9 per cent of all the shares in the company. Only the unrestricted equity of the company can be used to repurchase own shares on the basis of the authorisation. Own shares can be repurchased at a price formed in public trading on the date of the repurchase or otherwise at a price formed on the market. The Board of Directors decides how own shares will be repurchased and/or accepted as pledge. Own shares can be repurchased using, inter alia, derivatives. Own shares can be repurchased otherwise than in proportion to the shareholdings of the shareholders (directed repurchase). Own shares may be repurchased and/or accepted as pledge in order to, inter alia, develop the capital structure of Finnair, to finance or carry out acquisitions, investments or other business transactions, or in order to use the shares as part of Finnair’s incentive and remuneration schemes. The authorisation would be effective for a period of 18 months from the resolution of the General Meeting and it would cancel the authorisation given by the General Meeting on 27 March 2014 to decide on the repurchase and/or acceptance as pledge of own shares. 16. Authorising the Board of Directors to decide on the disposal of the company's own shares The Board of Directors proposes that the Annual General Meeting would authorise the Board of Directors to decide on the disposal of own shares held by the company. The amount of shares to be disposed based on the authorisation shall not exceed 5,000,000 shares, which corresponds to approximately 3.9 per cent of all the shares in the company. The Board of Directors decides on all the conditions of the disposals, including to whom, at what price and in which manner the company's shares are disposed. The disposals may also be made in deviation from the shareholders’ pre-emptive rights for a weighty financial reason, such as using the shares to develop the company's capital structure, to finance or carry out acquisitions, investments or other business transactions, or in order to use the shares as part of Finnair’s incentive and remuneration schemes. The authorisation would be effective for a period of 18 months from the resolution of the General Meeting and it would cancel the authorisation given by the General Meeting on 27 March 2014 to decide on the disposal of the company's own shares. 17. Closing of the Meeting B. DOCUMENTS OF THE ANNUAL GENERAL MEETING The proposals for the decisions on the matters on the agenda of the General Meeting as well as this notice to the General Meeting are available on the company’s website at www.finnairgroup.com. The annual accounts, the report of the Board of Directors and the auditor’s report of Finnair Plc are available on the above-mentioned website on 4 March 2015 at the latest. The proposals for decisions and other above-mentioned documents are also available at the Meeting. Copies of these documents and of this notice will be sent to shareholders upon request. The minutes of the Meeting will be available on the above-mentioned website as from 8 April 2015 at the latest. C. INSTRUCTIONS FOR THE PARTICIPANTS IN THE GENERAL MEETING 1. Shareholders registered in the shareholders’ register Each shareholder, who on the record date of the General Meeting, Friday 13 March 2015, is registered in the shareholders’ register of the company held by Euroclear Finland Ltd., has the right to participate in the General Meeting. A shareholder, whose shares are registered on his/her personal Finnish book-entry account, is registered in the shareholders’ register of the company. A shareholder, who is registered in the shareholders’ register of the company and who wants to participate in the General Meeting, shall register for the Meeting no later than by Friday 20 March 2015 by 10.00 a.m. (EET) by giving a prior notice of participation, which has to be received by the company before the end of the registration period. Such notice can be given: a) on the company’s website at www.finnairgroup.com; b) by e-mail to agm@finnair.com; c) by telephone +358 (0)20 770 6866 Monday through Friday from 9:00 to 16:00 (EET); d) by telefax +358 (0)9 694 0205; or e) by regular mail to Finnair Plc, Register of Shareholders AAC/502, 01053 FINNAIR. In connection with the registration, a shareholder shall notify his/her name, personal identification number, address, telephone number and the name of a possible assistant or proxy representative and the personal identification number of a proxy representative. The personal data given to Finnair Plc is used only in connection with the General Meeting and with the processing of related registrations. The shareholder, his/her authorised representative or proxy representative shall, where necessary, be able to prove his/her identity and/or right of representation. 2. Holders of nominee registered shares A holder of nominee registered shares has the right to participate in the General Meeting by virtue of such shares, based on which he/she on Friday 13 March 2015 would be entitled to be registered in the shareholders’ register of the company held by Euroclear Finland Ltd. The right to participate in the General Meeting requires, in addition, that the shareholder on the basis of such shares has been registered into the temporary shareholders’ register held by Euroclear Finland Ltd. at the latest by Friday 20 March 2015 by 10.00 a.m. (EET). As regards nominee registered shares this constitutes due registration for the General Meeting. A holder of nominee registered shares is advised to request without delay the necessary instructions regarding the registration in the temporary shareholder’s register of the company, the issuing of proxy documents and registration for the General Meeting from his/her custodian bank. The account management organisation of the custodian bank has to register a holder of nominee registered shares, who wants to participate in the General Meeting, into the temporary shareholders’ register of the company at the latest by the time stated above. 3. Proxy representative and powers of attorney A shareholder may participate in the General Meeting and exercise his/her rights at the Meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the General Meeting. When a shareholder participates in the General Meeting by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the General Meeting. Possible proxy documents should be delivered in originals to Finnair Plc, Register of Shareholders AAC/502, 01053 FINNAIR on Friday 20 March 2015 at the latest. 4. Other information Pursuant to chapter 5, section 25 of the Companies Act, a shareholder who is present at the General Meeting has the right to request information with respect to the matters to be considered at the Meeting. On the date of this notice to the Annual General Meeting, 26 February 2015, the total number of shares and votes in the company is 128,136,115. The company or its subsidiaries hold 312,092 of the company’s own shares, which do not have voting rights in the General Meeting. In Helsinki, 26 February 2015 FINNAIR PLC The Board of Directors

Carfinance247 named one of the Best UK Small Companies

The awards are based on the results of independent and extensive research of employee opinions. Carfinance247 was hailed as a caring employer who rewards hard work and gets the most from their staff with a number of initiatives. For example: · Monthly team events such as ten pin bowling, and Halloween fancy dress competitions to stop staff from getting bored, and to generate team spirit (90% of employees enjoy working with each other); · Monthly awards and discounts at retailers for high performers or those who have done something exceptional; · Fund raising events where the amounts raised are matched by Carfinance247; · Monthly staff gatherings with free pizza, cakes and drinks; · Making sure the staff have everything they need to do their job properly (86% staff satisfaction was reported); The study of staff also showed 73% of the staff felt they were fairly paid compared to people in similar roles, and 81% said the company is genuinely environmentally friendly. Directors and co-founders Reg and Louis Rix attended the event and are thrilled that their staff have such enthusiasm for working at the company. Louis says: “To be named as one of the Best 100 Small Companies To Work For based on our employees’ feedback, confirms that our commitment to making a fun, thriving and entrepreneurial environment is working. Our ethos is that happy, motivated staff, who get rewarded for going that extra mile, equals exceptional, first class, customer service. “To have such public recognition is the icing on the cake for us, as we strongly believe that a happy team means happy customers. It is great news to be independently acknowledged for our company culture and one we will continue to expand upon.” Ends

Annual General Meeting of AB Volvo

Shareholders who wish to participate at the Annual General Meeting must be recorded as a shareholder in AB Volvo’s share register on March 26, 2015 and must also give notice of their intention to participate at the Meeting to AB Volvo no later than March 26, 2015. Notice of intention to participate at the Meeting may be given from March 2, 2015 by telephone to +46 8 402 90 76, or by mail addressed to AB Volvo (publ), “AGM”, P O Box 7841, SE-103 98 Stockholm, Sweden, or directly on AB Volvo’s website: www.volvogroup.com. Please note that notice of intention to participate could be given per telephone no later than 4.00 p.m. on March 26, 2015. Media wishing to participate at the Meeting can notify their intention to Media Relations, AB Volvo, at +46 31 323 72 29. The notice to attend the Annual General Meeting follows below. Welcome!AB Volvo February 26, 2015 For more news from the Volvo Group, visit http://www.volvogroup.com/globalnews. The Volvo Group is one of the world’s leading manufacturers of trucks, buses, construction equipment and marine and industrial engines. The Group also provides complete solutions for financing and service. The Volvo Group, which employs about 100,000 people, has production facilities in 19 countries and sells its products in more than 190 markets. In 2014 the Volvo Group’s sales amounted to about SEK 283 billion and is listed on Nasdaq Stockholm. For more information, please visit www.volvogroup.com or www.volvogroup.mobi if you are using your mobile phone. Translation of Swedish original ANNUAL GENERAL MEETING OF AB VOLVO (publ) AB Volvo (publ) hereby gives notice to attend the Annual General Meeting at Konserthuset, Götaplatsen, Göteborg, Wednesday, April 1, 2015, at 3.00 p.m. Registration to the Annual General Meeting starts at 1.30 p.m. Proposed agenda Matters: 1.                   Opening of the Meeting 2.                   Election of Chairman of the Meeting 3.                   Verification of the voting list 4.                   Approval of the agenda 5.                   Election of minutes-checkers and vote controllers 6.                   Determination of whether the Meeting has been duly convened 7.                   Presentation of the work of the Board and Board committees 8.                   Presentation of the Annual Report and the Auditor’s Report as well as the Consolidated Accounts and the Auditor’s Report on the Consolidated Accounts. In connection therewith, speech by the President 9.                   Adoption of the Income Statement and Balance Sheet and the Consolidated Income Statement and Consolidated Balance Sheet 10.                 Resolution in respect of the disposition to be made of the Company’s profits 11.                 Resolution regarding discharge from liability of the members of the Board and of the President 12.                 Determination of the number of members and deputy members of the Board of Directors to be elected by the Meeting 13.                 Determination of the remuneration to be paid to the Board members 14.                 Election of the Board members and Chairman of the Board 15.                 Election of members of the Election Committee 16.                 Resolution on the adoption of a Remuneration Policy for senior executives Motions Point 2: The Election Committee proposes Sven Unger, Attorney at law, to be the Chairman of the Meeting. Point 10: The Board of Directors proposes payment of a dividend of SEK 3.00 per share. Tuesday, April 7, 2015, is proposed as the record date to receive the dividend. If the Annual General Meeting resolves in accordance with the proposal, payment of the dividend is expected to be performed through Euroclear Sweden AB on Friday, April 10, 2015. Point 12: The Election Committee proposes ten members and no deputy members. Point 13: The Election Committee proposes that the Board remuneration remains unchanged, meaning that the Chairman of the Board is awarded SEK 3,250,000 and each of the other Board members elected by the Annual General Meeting SEK 950,000 with the exception of the President. Furthermore, the Election Committee proposes that the remuneration for Board Committee work remains unchanged, meaning that the Chairman of the Audit Committee is awarded SEK 300,000 and the other members of the Audit Committee SEK 150,000 each and that the Chairman of the Remuneration Committee is awarded SEK 125,000 and the other members of the Remuneration Committee SEK 100,000 each. Point 14: Jean-Baptiste Duzan will not stand for re-election. The Election Committee proposes re-election of Matti Alahuhta, James W. Griffith, Kathryn V. Marinello, Hanne de Mora, Anders Nyrén, Olof Persson, Carl-Henric Svanberg and Lars Westerberg. The Election Committee proposes new election of Martina Merz and Eckhard Cordes. The Election Committee further proposes re-election of Carl-Henric Svanberg as Chairman of the Board. A presentation of the candidates proposed by the Election Committee is available on AB Volvo’s website; www.volvokoncernen.se or www.volvogroup.com. Point 15: The Election Committee proposes that Carl-Olof By, representing AB Industrivärden, Lars Förberg, representing Cevian Capital, Yngve Slyngstad, representing Norges Bank Investment Management, Håkan Sandberg, representing Svenska Handelsbanken, SHB Pension Fund, SHB Employee Fund, SHB Pensionskassa and Oktogonen, and the Chairman of the Board of Directors are elected members of the Election Committee and that no fees are paid to the members of the Election Committee. Point 16: The Board of Directors proposes that the Annual General Meeting resolves to adopt the following Remuneration Policy for senior executives. This Policy concerns the remuneration and other terms of employment for the Volvo Group Executive Team. The members of the Volvo Group Executive Team, including the President and any possible Deputy President, are in the following referred to as the “Executives”. This Policy will be valid for employment agreements entered into after the approval of the Policy by the Annual General Meeting and for changes made to existing employment agreements thereafter. 1       Guiding principles for remuneration and other terms of employment           The guiding principle is that the remuneration and the other terms of employment for the Executives shall be competitive in order to ensure that the Volvo Group can attract and retain competent Executives. The Annual Report 2014 sets out details on the total remuneration and benefits awarded to the Executives during 2014. 2       The principles for fixed salaries The Executive’s fixed salary shall be competitive and based on the individual Executive’s responsibilities and performance. 3       The principal terms of variable salary and incentive schemes, including the relation between fixed and variable components of the remuneration and the linkage between performance and remuneration The Executives may receive variable salaries in addition to fixed salaries. The variable salary may, as regards the President, amount to a maximum of 75% of the fixed annual salary and, as regards the other Executives, a maximum of 60% of the fixed annual salary. The variable salary may be based on inter alia the performance of the entire Volvo Group or the performance of a certain part of the Group where the Executive is employed. The performance will be related to the fulfilment of various improvement targets or the attainment of certain financial objectives. Such targets will be set by the Board and may relate to inter alia operating income, operating margin or cash flow. The Board may under certain conditions decide to reclaim variable salary already paid or to cancel or limit variable salary to be paid to the Executives. The Annual General Meeting 2014 decided to adopt a share-based incentive program for senior executives in the Volvo Group relating to the financial years 2014, 2015 and 2016. 4       The principal terms of non-monetary benefits, pension, notice of termination and severance pay 4.1    Non-monetary benefits The Executives will be entitled to customary non-monetary benefits such as company cars and company health care. In addition thereto in individual cases company housing and other benefits may also be offered. 4.2    Pension In addition to pension benefits which the Executives are entitled to according to law and collective bargaining agreements, Executives resident in Sweden may be offered two different defined-contribution plans with annual premiums. For the first plan the annual premiums amount to SEK 30,000 plus 20% of the pensionable salary over 30 income base amounts and for the second plan the annual premiums amount to 10% of pensionable salary. In the two defined-contribution plans, the pension earned will correspond to the sum of paid-in premiums and possible return without any guaranteed level of pension received by the employee. Further no definite retirement date is set in the two plans but premiums will be paid for the employee until his or her 65th birthday. Executives resident outside Sweden or resident in Sweden but having a material connection to or having been resident in a country other than Sweden may be offered pension benefits that are competitive in the country where the Executives are or have been resident or to which the Executives have a material connection, preferably defined-contribution plans. 4.3      Notice of termination and severance pay For Executives resident in Sweden, the termination period from the Company will be 12 months and 6 months from the Executive. In addition thereto, the Executive, provided that termination has been made by the Company, will be entitled to 12 months’ severance pay. Executives resident outside Sweden or resident in Sweden but having a material connection to or having been resident in a country other than Sweden may be offered notice periods for termination and severance payment that are competitive in the country where the Executives are or have been resident or to which the Executives have a material connection, preferably solutions comparable to the solutions applied to Executives resident in Sweden. 5       The Board’s preparation and decision-making on issues concerning remuneration and other terms of employment for the Volvo Group Executive Team The Remuneration Committee is responsible for (i) preparing the Board’s decisions on issues concerning principles for remuneration, remunerations and other terms of employment for Executives, (ii) monitoring and evaluating programs for variable remuneration, both ongoing and those that have ended during the year, for Executives, (iii) monitoring and evaluating the application of this Policy, and (iv) monitoring and evaluating current remuneration structures and levels in the Company. The Remuneration Committee prepares and the Board decides on (i) terms of employment and remuneration of the President and the Deputy President, if any, and (ii) principles for remuneration (incl. pension and severance pay) for the Executives. The Remuneration Committee shall approve proposals on remuneration of the members of the Volvo Group Executive Team. The Remuneration Committee is further responsible for the review and recommendation to the Board of share and share price related incentive programs to be decided upon by the Annual General Meeting. 6         Authority to decide on deviations from this Policy The Board of Directors may deviate from this Policy if there are specific reasons to do so in an individual case. Documents The proposals by the Election Committee and its statement explaining the proposals are available at www.volvogroup.com and www.volvokoncernen.se. The Annual Report, the Auditor’s Report and the Auditor’s statement pursuant to Chapter 8, Section 54 of the Swedish Companies Act will be available at www.volvogroup.com and www.volvokoncernen.se, and at AB Volvo’s Headquarters, Amazonvägen, Torslanda, Göteborg, from March 11, 2015 at the latest. The documents will be sent on request to such shareholders who provide their address from the date they become available. The documents will also be available at the Annual General Meeting. The number of shares and votes When this notice to attend the Annual General Meeting was issued, the total number of shares in the Company was 2,128,420,220, distributed among 513,114,267 series A shares (1 vote per series A share), and 1,615,305,953 series B shares (1/10 vote per series B share). The total number of votes was 674,644,862.3. The Company’s holding of own shares amounted to 98,478,930, distributed among 20,728,135 series A shares and 77,750,795 series B shares, corresponding to 28,503,214.5 votes. The Company may not vote using its treasury shares. Information at the Annual General Meeting Upon request by any shareholder and where the Board of Directors believes that such may take place without significant harm to the Company, the Board of Directors and the President should provide information at the Annual General Meeting in respect of any circumstances which may affect the assessment of a matter on the agenda, and any circumstances which may affect the assessment of the Company’s or a subsidiary’s financial position and as regards the Company’s relationship to other group companies. Right to participate in the Annual General Meeting Participation in AB Volvo’s Annual General Meeting is limited to those who are recorded as shareholders in the share register maintained by Euroclear Sweden AB on March 26, 2015 and who give notice of their intention to participate in the Annual General Meeting to AB Volvo no later than March 26, 2015. Shares registered in the name of a nominee To be entitled to participate in the Annual General Meeting, shareholders having their shares registered in the name of a nominee must request the nominee to enter the shareholder into the share register. Such registration, which can be temporary, must have been effected by March 26, 2015 and should therefore be requested well in advance of March 26, 2015. Nominees normally charge a fee for this. Notice Notice of intention to participate in the Annual General Meeting can be given from March 2, 2015: •  by telephone, +46 8 402 90 76 •  by mail addressed to AB Volvo (publ), “AGM”, P.O. Box 7841, SE-103 98 Stockholm, Sweden •  on AB Volvo’s website; www.volvogroup.com and www.volvokoncernen.se In providing such notice, the shareholder should state: •  name                                                                                                   •  personal registration number (corporate registration number) •  address and telephone number •  name and personal registration number of the proxy, if any •  the number of any accompanying assistant(s) (maximum two assistants) Shareholders who wish to participate in the Annual General Meeting must submit notice prior to expiration of the notice period on March 26, 2015. If you wish to be accompanied by an assistant, notification to this effect must be provided as specified above. Please note that notice of intention to participate could be given per telephone no later than 4.00 p.m. on March 26, 2015. Shareholders who are represented by proxy must issue a written, dated proxy for the representative. Such proxy forms are available at www.volvogroup.com or www.volvokoncernen.se. The proxy, in its original, should be sent to the Company at the above address in good time prior to the Annual General Meeting. The proxy may not be older than one year unless it states that it is valid for a longer period of time, although the validity of the proxy may not exceed five years. If the proxy is issued by a legal entity, a certified copy of the registration certificate or an equivalent certificate of authority must be submitted to the company. Note that shareholders who are represented by proxy must notify the Company of their participation according to the above instructions and be registered as shareholders in the share register on March 26, 2015. Miscellaneous The main entrance of Konserthuset opens at 1.30 p.m. A light meal will be served in the foyer before the Annual General Meeting.  Göteborg, February 2015 AB Volvo (publ) The Board of Directors

Why Natural Gas Prices are Headed Much Lower

     Coming into this winter you wouldn't have found a bigger bull, than myself, when it concerned natural gas prices. The frigid memories of last winter were still in my head, and we were entering this one with a large deficit in natural gas inventories. A funny thing happened--winter for a large part of the country west of the Mississippi, was never more than a few small instances of snow and ice. The same of course could not be said for the east coast with record snowfall and bitter cold for much of February. And that's the point; it was only February, the beginning of the winter for the northeast was almost pleasant. When you coupled the lack of sustained cold with the amazing production gains in natural gas it was a recipe for lower prices--and ones that could go much lower from here in my opinion. We just finished one of the coldest weeks on record and the draw in natural gas fell well short of expectations when the number was released earlier today. This is happening because of the production gains in fracking --just as in crude oil, the fracking revolution has permeated the natural gas markets. We are now almost 50% above supply figures than we were last year at this time. When you look at the calendar you realize there are about 4 weeks of winter left. This is one of the best scenarios someone looking to short Nat gas could ask for ; projected lower demand and higher production. For these reasons this bull has now become a bear--I am looking to sell the market-- the 50 day Moving average comes in around 293 and offers good resistance.  My belief is you could short Natural gas within 10 handles of this level. If temps moderate quickly this spring and production of Nat gas continues at its current pace--we could see a 230 to 220 handle in prices by April. We are entering what I call the in-between season where Nat gas is not used for heating or cooling--demand falls considerably.Anthony Grisanti --President GRZ Energy

BMW named UK Car of the Year 2015

The BMW i8 plug-in hybrid sports car has been crowned UK Car of the Year for 2015. Having fought off stiff competition to the title of Performance Car of the Year, the four-seat technological tour de force also won the overall vote. Launched in 2014, the UK Car of the Year Awards are judged by 27 of Britain’s most-read motoring journalists. Each judge uses their expertise to pick out the top performer in 12 vehicle categories, before deciding the overall winner from their favourites in each class. The win for the i8 – powered by combination of a 1.5-litre, three-cylinder engine and 96kW electric motor – means back-to-back wins for the BMW ‘i’ brand at the UK Car of the Year Awards. Twelve months ago, the German manufacturer was picking up the inaugural title for its i3 small car. “The automotive industry has seen many hybrid models in recent years, but nothing quite like the i8,” said John Challen, Managing Director of UK Car of the Year Awards, and Editor of ukcoty.co.uk. “The term ‘game-changer’ is sometimes overused when talking about new cars, but in the case of the i8, it is totally justified. The latest ‘i’ model completely redefines the performance car segment, and is helped by a hybrid powertrain that is really quite special.” Graeme Grieve, BMW UK CEO commented: “The BMW i8 is the culmination of many years of investment, hard work and commitment to create the world’s most progressive sports car. With our first two BMW i vehicles – the i3 and i8 – being named consecutive UK Car of the Year winners, our technology strategy is being recognised as truly game-changing for the car industry.” Several of the UK Car of the Year judges were quick to praise the triumphant car.  Paul Hudson from The Telegraph said it was “a fantastic demonstration that an electrically-powered future need not be dull”, while Graeme Lambert from Parkers added: “The i8 represents the future. It also shows us that being excited and being eco-conscious behind the wheel aren’t mutually exclusive.” “The BMW i8 basically reinvents the performance car. Stunning to look at, and amazing to drive, there's nothing else like it out there,” was HonestJohn.co.uk’s David Ross’ verdict, while Top Gear’s Tom Ford described the i8 as “hybrid, clever, exciting – the i8 manages to be a consummate driving experience.” In the overall Car of the Year class, which included vehicles as disparate as the Volkswagen Passat Estate and the Rolls-Royce Ghost, 14 of the 27 judges chose the BMW as their winner. The nearest challenger was the Citroën C4 Cactus, followed by the Renault Twingo in third place. Full list of UK Car of the Year Awards 2015 winners: · Best City Car - Renault Twingo · Best Supermini – Skoda Fabia · Best Small Hatch – Citroën C4 Cactus · Best Family Car – Ford Mondeo · Best Executive Car – Mercedes-Benz C-Class · Best Luxury Car – Rolls-Royce Ghost · Best Estate Car – Volkswagen Passat · Best MPV – BMW 2 Series Active Tourer · Best 4x4 – Porsche Macan · Best Coupé – Jaguar F-TYPE · Best Open Top Car – Porsche Boxster GTS · Best Performance Car – BMW i8 For more information about the UK Car of the Year Awards, go to ukcoty.co.uk Ends Image captions: · Graeme Grieve, BMW UK CEO (right), with John Challen, managing director of UK Car of the Year · The BMW i8 has been voted winner of the title of UK Car of the Year 2015 · Established in 2014, the UK Car of the Year Awards are voted for by a panel of 27 leading motoring journalists Contact: John Challen; Tel: 07803 237285; Email: jchallen@ukcoty.co.uk For media enquires contact: Marco Ferrari at Torque; Tel: 020 7952 1070; Email: mferrari@torqueagencygroup.com

TROAX ANNOUNCES ITS INTENTION TO PROCEED WITH AN INITIAL PUBLIC OFFERING AND LISTING ON NASDAQ STOCKHOLM

Hillerstorp 27 February 2015, 07.00 CET Nasdaq Stockholm has decided to admit Troax’ shares to trading, subject to customary conditions, such as a prospectus being approved by the Swedish Financial Supervisory Authority, the distribution requirements in respect of the Company’s shares being fulfilled no later than on the first day of trading and approval from the board of the principal shareholder. Depending on market conditions, the listing is expected to be completed during the first half of 2015. The IPO will comprise existing shares primarily sold by the Company’s current principal owner FSN Capital LP III. The shares will be offered to qualified institutional investors in Sweden and internationally, as well as to the public in Sweden. The IPO will broaden the Company’s shareholder base and make it possible for Troax to use the Swedish and international capital markets to increase the Company’s financing options for future growth, both organically and through selective acquisitions. Carnegie Investment Bank is acting as Global Coordinator and Handelsbanken Capital Markets is acting as Joint Bookrunner. Troax highlights · Troax is the global market leader in metal-based mesh panel solutions in its three core business areas; Automation and Robotics, Material Handling and Logistics and Property Protection · Troax underlying market is characterized by structural growth from increased automation, safety and e-commerce trends · In its main addressable geographical market, Europe, the Company has a market share of around 20 percent. Troax global market share is 10 percent and Troax is almost two and a half times larger than its closest competitor · Troax is currently represented in 31 countries with 35 sales offices and 7 distribution hubs employing approximately 400 employees · 2014 pro forma sales and adjusted EBITDA amounted to EUR 91.2m and EUR 18.6m · In 2014, 54% of net sales was generated in Mainland Europe, 19% in the Nordics, 17% in the United Kingdom and 6% in New Markets +----------------------+-----+-----+-----------+|  |1 January – 31 December|+----------------------+-----+-----+-----------+|MEUR | IFRS| IFRS| Pro forma*|+----------------------+-----+-----+-----------+|  | 2013| 2014| 2014|+----------------------+-----+-----+-----------+|Net sales | 70.1| 84.5| 91.2|+----------------------+-----+-----+-----------+|Adj. EBITDA | 12.5| 17.2| 18.6|+----------------------+-----+-----+-----------+|Adj. EBITDA margin (%)|17.9%|20.4%| 20.5%|+----------------------+-----+-----+-----------+|Adj. EBITA | 10.7| 15.4| 16.7|+----------------------+-----+-----+-----------+|Adj. EBITA margin (%) |15.2%|18.2%| 18.4%|+----------------------+-----+-----+-----------+ * Pro forma includes full year financials 2014 for Troax and Satech (acquired in June 2014)  For additional information, please contact: Thomas Widstrand, CEOPhone: +46 370 828 31 Ola Österberg, CFOPhone: +46 370 828 25  IMPORTANT INFORMATION This announcement is not and does not form a part of any offer for sale of securities. Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada, Japan or any other jurisdiction in which such distribution would be unlawful or would require registration or other measures. The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and accordingly may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company does not intend to register any offering in the United States or to conduct a public offering of securities in the United States. Any offering of the securities referred to in this announcement will be made by means of a prospectus. This announcement is not a prospectus for the purposes of Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”). Investors should not invest in any securities referred to in this announcement except on the basis of information contained in the aforementioned prospectus. In any EEA Member State other than Sweden that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State. This communication is only being distributed to and is only directed at persons in the United Kingdom that are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”) or (ii) high net worth entities, and other persons to whom this announcement may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). This communication must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only to relevant persons and will be engaged in only with relevant persons. Persons distributing this communication must satisfy themselves that it is lawful to do so. Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as “believe,” “expect,” “anticipate,” “intends,” “estimate,” “will,” “may,” "continue," “should” and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although Troax believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The information, opinions and forward-looking statements contained in this announcement speak only as at its date, and are subject to change without notice.

Year-end report 2014

BUSINESS UPDATEAfter a challenging period during the first six months of the year when net sales declined due to significant stock-outs, the development in net sales improved during the last six months of the year, and in particular during the last quarter. As the incremental revenue added during the fourth quarter was associated with a higher than average gross margin, this increase in net sales had a fundamental impact on the company’s results as we were able to achieve a better leverage of our existing organizational structure. Adjusted for currencies, the company achieved an important internal ambition by presenting a positive EBITDA of SEK 1.9 million for the fourth quarter. The increase in net sales during the fourth quarter primarily resulted from the new tender in Spain, where the first volumes were supplied during the period, as well as the initial deliveries to our partner in Iraq but also a general increase in contribution from other markets. Establishment in new marketsDuring 2014, the company signed an agreement with a local distributor in Iraq for marketing of a selection of Bluefish products in this region. The initial deliveries were supplied during the fourth quarter, and the remaining goods will be shipped during the first six months of 2015. During the year, Bluefish has also established a local company in Dubai, from where we will have a broad coverage of several markets, including the Middle East, North- and Sub-Saharan Africa. We have established a partnership with Tranzone, a local logistics company, who will handle the distribution of products for these markets. The aim is to grow the business in this territory together with existing and new partners by launching additional products as well as securing new and repeat orders. Development projects progressingSeveral of the company’s proprietary formulation projects are reaching the final stages of development. For the most advanced product, the health authorities in Sweden have confirmed a slot for submission of the registration file in March 2015. The procedure will include several of Bluefish key markets, with market launches expected in 2016. In addition, the company is actively seeking partners for this product in markets outside Bluefish territories. The development project pipeline is expected to contribute to net sales growth in 2016 and beyond. New share issue and extension of convertible debtDuring the second quarter of 2014, the company completed a new share issue of SEK 50 million with funds primarily provided by the company’s largest shareholders. Further, the offer to extend the holding in the convertible debt until 30 June 2017 was accepted by holders of debt equivalent to SEK 21.7 million, while SEK 18.4 million was repaid in June 2014. At the end of the year, total net debt amounted to SEK 56.4 million compared to SEK 60.2 million at the beginning of the year. OUTLOOKThe relative contribution from each market will fluctuate over time, however, we expect that net sales in 2015 will grow. The increase will come from already secured tenders, planned new product launches as well as a general increase in market share. The expansion in gross margin is expected to continue, however, not in parity with that of the fourth quarter of 2014. With an expected increase in revenues, together with an expansion of the gross margin, we anticipate a positive EBITDA in 2015.

Change in number of shares and votes in Aerocrine etc.

With reference to Chapter 4 Section 9 in the Swedish Financial Instruments Trading Act, it is hereby announced that as a result of the recent rights issue in Aerocrine AB (Nasdaq Stockholm: AERO), the number of shares and votes in Aerocrine has increased during February 2015 as specified in the table below.  Number of shares and votesFebruary 1, 2015 155,416,387Increase 542,721,067February 27, 2015 698,137,454 It is further announced that Rolf Classon now has resumed his position as chairman of the Board of Directors, after being on sick leave since December 2014.  Solna February 27, 2015 Aerocrine AB (publ.) For further information, please contact: Marshall Woodworth, CFO, +1 919 749 8748 or +46 709 695 219 About Aerocrine Aerocrine AB is a medical products company focused on improved management and care of patients with inflammatory airway diseases such as Asthma. Within this sector, Aerocrine is the world leader. Aerocrine markets NIOX MINO® and NIOX VERO®, which enables fast and reliable point-of-care measurement of airway inflammation. These products plays a critical role in more effective diagnosis, treatment and follow-up of patients affected with inflammatory airway diseases. Aerocrine is based in Sweden with subsidiaries in the US, Germany, Switzerland and the UK. Aerocrine shares have been listed on the Stockholm Stock Exchange since 2007 (AERO-B.ST). For more information please visit www.aerocrine.com and www.niox.com. +-----------------------------------------------------------------------------+|Aerocrine is required to disclose the information provided herein pursuant to||the Securities Markets Act and/or the Financial Instruments Trading Act. The ||information was submitted for publication at 08:00 am on February 27, 2015. |+-----------------------------------------------------------------------------+

Trigon Agri A/S 4Q 2014 Interim Report

Highlights of 2014 Total revenue, other income, fair value adjustments and net changes in inventory amounted to EUR 74.5 million (EUR 75.4 million in 2013). EBITDA was a profit of EUR 13.6 million (loss of EUR 1.1 million in 2013). The Net loss was EUR 13.3 million (loss of EUR 16.8 million in 2013). Please note that the result includes EUR 12.3 million of non-cash currency translation losses due to the dramatic depreciation of the Rouble and Hryvna. The consolidated assets as of December 31, 2014 amounted to EUR 149.6 million (EUR 185.2 million at December 31, 2013). Trigon Agri’s Founder and Chairman of the Board, Joakim Helenius, Comments: Trigon Agri achieved an EBITDA of EUR 13.6 million in 2014 versus a negative EBITDA of EUR 1.1 million in 2013. This result was achieved despite the continued low soft commodity prices which in real terms for the second year running have remained near their historical all-time lows. In fact the actual prices achieved by Trigon Agri in 2014 were even lower than in 2013. Our continued focus on costs and operational efficiencies helped to achieve this result. Despite the good EBITDA result given the circumstances the net profit was severely impacted by non-cash currency translation losses driven by the dramatic drop in value of both the Ukrainian Hryvna and the Russian Rouble. Out of the reported net loss of EUR 13.3 million non-cash currency translation losses amounted to EUR 12.3 million. The dramatic currency depreciation has also significantly impacted the value of our assets measured in euros. The overall situation in the agricultural sectors of both Russia and Ukraine is strongly impacted by the political, economic and financial situation in the region. Trigon Agri itself has secured the working capital it needs for the 2015 season, however it would appear based on anecdotal evidence that a significant part of the agricultural producers are having serious trouble financing their working capital needs given the stressed state of the banking sectors in the two countries. This could mean that the regional harvest in 2015 will be negatively affected, possibly significantly so. Everything else being equal this should be positive for likely price developments in the region, assuming no export restrictions (such as the current Russian ones). As has been stated in a separate stock exchange release yesterday Trigon Agri bondholders voted unanimously to support an extension of the maturity of the bonds to August 2017. This gives us additional time to continue implementing our previously communicated divestment strategy, selling non-core assets in order to repay the bonds. Telephone conference details A telephone conference will be held today, on February 27, 2015 at 10.00 CET. Program: Joakim Helenius, Chairman of the Board, and Ülo Adamson, President and CEO, will present and comment upon the results. There will also be an opportunity to ask questions. To participate in the telephone conference, please call one of the following numbers: SE: +46 8 505 564 74 UK: +44 203 364 5374 US: +1 855 753 2230 FI: +358 981710460 NO: +47 235 002 10 DK: +45 354 45 580 CH: +41 225 675 541 The presentation material will be available on www.trigonagri.com before the telephone conference starts. A recording of the telephone conference will be available afterwards on www.trigonagri.com. Investor enquiries: Mr. Ülo Adamson, President and CEO of Trigon Agri A/S, Tel: +372 66 79200, E-mail: mail@trigonagri.com About Trigon Agri Trigon Agri is a leading integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Trigon Agri’s shares are traded on the main market of NASDAQ OMX Stockholm. Trigon Agri is managed under a management agreement by Trigon Capital, a leading Central and Eastern European operational management firm with around USD 1 billion of assets under management. For subscription to Company Announcements please contact us: mail@trigonagri.com. If you do not want to receive Trigon Agri press releases automatically in the future please send an e-mail to the following address: unsubscribe@trigonagri.com (mail@trigonagri.com).

Vattenfall wins concession for Horns Rev 3

Vattenfall Wind Power has won the concession to build and operate the offshore wind farm Horns Rev 3, with a total capacity of 400 MW. The wind farm will produce electricity for 450 000 households from 2017. Vattenfall’s CEO Magnus Hall welcomes the decision that Vattenfall had the most competitive bid. Now the company awaits approval from the Danish Parliament and EU. – The construction of Horns Rev 3 is an important step towards both Denmark’s and EU’s goals to reduce carbon dioxide emissions, goals that stipulate that 30 % of the total energy consumption in 2020 shall origin from renewable energy sources. For that reason, we trust the political majority to go along with the agreement and find a solution suitable for all parties, says Magnus Hall. – This large, planned offshore wind farm will affect Vattenfall’s ambitions concerning wind power and especially our focus on offshore wind farms. Today we are the second largest operator of offshore wind power farms in the world and one of the largest operators of on shore wind power in Denmark. That gives us even better ways and means to develop sustainable energy production to become both profitable and competitive – in benefit of the Danish consumers, says Magnus Hall. With Vattenfall as owner of the concession for Horns Rev 3, the company gets a unique opportunity for synergies between several offshore wind power farms, according to Alberto Mendez Rebollo, Head of Vattenfall Nordic Wind Power operations. – Our Control Center in Esbjerg today monitors more than 1000 wind turbines, offshore and on shore, and Horns Rev 3 will imply positive synergies in operation and maintenance of offshore wind farms in the Nordic Sea. Both the Control Center in Esbjerg and the community Esbjerg, will gain a more important role as a chain of support when Horns Rev 3 is in operation, says Alberto Mendez Rebollo. Offshore, Vattenfall owns 60 % of the wind farm Horns Rev 1, 80 wind turbines, and is currently building, together with Stadtwerke München, two offshore wind farms in the German part of the Nordic Sea: Dan Tysk and Sandbank. Besides that, Vattenfall is developing the wind farm Kentish Flats in the UK.In total, Vattenfall owns approximately 1800 MW, of which 1000 MW are offshore. For further information, please contact:Peter Stedt, Press Officer Vattenfall AB, +46 70 597 73 38 Vattenfall's Press Office,Phone: +46 (0) 8 739 50 10press@vattenfall.com Vattenfall is a Swedish owned energy company with operations in Sweden, Germany, the Netherlands, Denmark, UK, France and Finland. Vattenfall’s vision is to create a strong and diversified European energy portfolio and to be among the leaders in developing an environmentally sustainable energy systems.

myFC Debuts World’s Smallest Portable Fuel Cell Charger at Mobile World Congress

Barcelona, February 27th 2015 – Swedish innovation company myFC will premiere a new fuel cell charger, “JAQ,” at the Mobile World Congress. The new charger is a powerhouse –smaller, lighter, at a lower cost per charge, and a hefty improvement in capacity. The slimline card, which consists of ordinary water and salt and easily fits in a pocket or bag, represents a new way of charging. Users can easily charge mobile phones and tablets using the card, which lasts for one smartphone charge. No pre-charging in a power socket is needed as electricity is created instantly on the spot when the card is activated. The new charger debuts at the Mobile World Congress (booth 7F41, hall 7) and will be in stores in Q4 2015. “Mobile accessibility is critical for everyone and the demand for charging solutions for mobile phones, tablets, and cameras is increasing,” says Björn Westerholm, CEO of myFC AB. “The dramatic reduction of the size of both the fuel and charger allows for the charger to be slimmer, so as to nicely fit inside a jacket pocket, for example. This truly makes energy available whenever you need it.” Fuel cells use environmentally friendly technology to generate their own electricity, which can be used to charge one’s mobile phone, tablet, or camera completely independent of a power outlet or sunlight. For more information, please contact: Björn Westerholm, CEOE-mail: bjorn.westerholm@myfc.sePhone: +46 (0) 706 56 20 07 Press kit can be downloaded at:https://www.dropbox.com/sh/7cva3dhuqpi1xir/AADT3cMAKNaUSGNA80z4tICfa?dl=0

Financial Statement, January – December 2014

October to December 2014 (2013) · Net turnover totalled SEK 377.0 million (SEK 147.1 m), SEK 220.1 million (SEK 10.5 m) of which comprised royalties for simeprevir. · Revenues from Medivir’s own pharmaceutical sales totalled SEK 156.6 million (SEK 47.6 m), SEK 103.1 million (SEK 0) of which derived from sales of OLYSIO® and SEK 53.5 million (SEK 47.6 m) from sales of other pharmaceuticals. · The profit/loss after tax was SEK 147.3 million (SEK 19.3 m). · Basic and diluted earnings per share totalled SEK 4.71 (SEK 0.62) and SEK 4.67 (SEK 0.62), respectively. · The cash flow from operating activities amounted to SEK 505.4 million (SEK 75.6 m). January to December 2014 (2013) · Net turnover totalled SEK 1,767.0 million (SEK 446.1 m), SEK 1,399.0 million (SEK 10.5 m) of which comprised royalties for simeprevir. · Revenues from Medivir’s own pharmaceutical sales totalled SEK 366.8 million (SEK 176.1 m), SEK 186.4 million (SEK 0) of which derived from sales of OLYSIO® and SEK 180.4 million (SEK 176.1 m) from sales of other pharmaceuticals. · The profit/loss after tax was SEK 1,132.7 million (SEK 16.0 m). · Basic and diluted earnings per share totalled SEK 36.24 (SEK 0.51) and SEK 35.90 (SEK 0.51), respectively. · The cash flow from operating activities amounted to SEK 1,009.4 million (SEK 43.0 m). · Liquid assets and short-term investments at the period end totalled SEK 1,395.6 million (SEK 402.2 m). The royalties from the current quarter are not included in these items. Significant operational events During Q4 2014 · A Capital Markets Meeting focusing on the updated company strategy was held on 16 October. · Medivir presented data from the cathepsin S inhibitor programme for the treatment of neuropathic pain at the 15th World Congress on Pain. · The launch of the phase II study, IMPACT, for the evaluation of simeprevir in combination with sofosbuvir and daclatasvir in patients with decompensated cirrhosis of the liver was announced.     · Medivir entered into an agreement with Swedish county councils regarding risk sharing in connection with the treatment of hepatitis C with OLYSIO®. The agreement offers the county councils and Medivir an increased degree of predictability with regard to treatment costs and the use of OLYSIO®. · The U.S. Food and Drug Administration (FDA) approved OLYSIO® (simeprevir) in combination with sofosbuvir as an all-oral, interferon- and ribavirin-free treatment option. · Medivir convened an Extraordinary General Meeting on Thursday, 20 November 2014, at which a voluntary share redemption programme for a total of ca. SEK 625 million was approved. The programme will be conducted during the first quarter of 2015. · MIV-802 was selected as a candidate drug for Medivir’s nucleotide-based polymerase inhibitor project for the treatment of hepatitis C. After the end of Q4 · Global net sales of OLYSIO® (simeprevir) totalled USD 321 million, USD 256 million of which derived from sales in the USA during the fourth quarter of 2014. Medivir’s royalties amounted to SEK 220.1 million (EUR 23.1 m). · Medivir announced a reorganisation of the company’s management group effective 1 March 2015. · The terms and schedule for the voluntary share redemption programme were announced. · The phase II studies, COMMIT, for the evaluation of simeprevir in combination with daclatasvir and ACCORDION-I for the evaluation of simeprevir in combination with daclatasvir and sofosbuvir, began. · The Nomination Committee proposed a new Board of Directors, ahead of the 2015 Annual General Meeting. * All figures refer to the Group, unless otherwise stated. Comparisons in the Interim Report are, unless otherwise stated, with the corresponding period in 2013. Cross Pharma was divested from the Group on 30 June 2013. The CEO’s statement Our ongoing hepatitis C research has resulted in a new candidate drug2014 has been an historic year for Medivir. The most important event was, of course, the launch of OLYSIO®, a new pharmaceutical for the treatment of hepatitis C and which was developed in collaboration with our partner, Janssen. The launch has resulted in substantial income streams for Medivir, both from own pharmaceutical sales within the Nordic region, and in the form of royalty income through our partner, Janssen, from sales in other markets. Royalty income for these sales in the fourth quarter and the year as a whole totalled SEK 220.1 million and SEK 1,399.0 million, respectively. Medivir’s own Nordic market sales of OLYSIO® in the fourth quarter totalled SEK 103.1 million, while sales since the launch in the second quarter of 2014 now amount to SEK 186.4 million. The global hepatitis C market is an exciting one with an ongoing significant dynamic where only an extremely small propotion of diagnosed patients have received treatment to date. A number of new pharmaceuticals for the treatment of hepatitis C have been introduced, both internationally and on the Nordic market, in 2014, resulting in an increase in the competition faced by OLYSIO®. The Swedish Dental and Pharmaceutical Benefits Agency (TLV) has, however, stated that treatment with OLYSIO® is beneficial from a health economics viewpoint in the treatment of hepatitis C patients, and this past autumn saw a risk-sharing agreement reached between Medivir and the Swedish county councils offering both parties an increased degree of predictability with regard to treatment costs and the use of OLYSIO®. In November, Medivir’s partner, Janssen, presented real-world data for treatment with simeprevir and sofosbuvir, with and without ribavirin. These data were very positive and confirmed the positive results presented in the COSMOS study. The treatment results demonstrate a very high cure rate and a good safety profile, which is a very positive outcome now that competition is growing in the global market. Our research portfolio is developing according to plan. In December, MIV-802 was selected as a candidate drug from our internal nucleotide-based polymerase inhibitor project for the treatment of hepatitis C and has, in our opinion, every chance of proving a valuable addition to the pharmaceuticals currently available. The project has now entered the non-clinical development phase and we intend to present MIV-802’s antiviral and pharmacokinetic profiles in 2015. Our in-house development projects are currently conducting important preclinical safety studies. Cathepsin S is a protease that plays an important role in long-term neuropathic pain. In October, we presented data from the project involving our candidate drug, MIV-247, a cathepsin S inhibitor currently in non-clinical development for the oral treatment of neuropathic pain. The results to date are very promising and we look forward to the continued development of a new, effective and safe treatment alternative for the substantial group of patients who suffer from chronic neuropathic pain. MIV-711 is a cathepsin K inhibitor in clinical development for the treatment of osteoarthritis. The positive results we have seen from the initial clinical phase I studies confirm that MIV-711 has the potential to offer disease-modifying treatment of skeletal and cartilage-related diseases such as osteoarthritis. Nordic pharmaceutical sales have performed well during the quarter. Nordic Brands continued to report stable sales of SEK 53.4 million during the fourth quarter and of SEK 180.0 million during 2014 as a whole. Innovative Specialty Care and Nordic Brands collectively generated sales of SEK 156.6 million during the quarter and of SEK 366.8 million during 2014 as a whole, corresponding to a year on year increase of SEK 190.7 million.   An Extraordinary General Meeting held in November approved a voluntary share redemption programme for ca. SEK 625 million for which the final terms, approved by the Board of Directors on 30 January 2015, mean that every seventh share will be redeemable for a cash consideration of SEK 140 per share. We can now put a successful year to rest and look forward to 2015. Medivir will continue to be a research-based pharmaceutical company and will, in order to strengthen and develop our research portfolio, continue to build on our cutting-edge expertise in protease inhibitor design and nucleotide/nucleoside research, with the emphasis on infectious diseases and oncology. We will intensify our activities in the commercial development sphere and within our already strong commercial organisation with the aim of identifying new business opportunities for both our R&D operations and our Nordic pharmaceutical portfolio – activities that will lead to increased value generation and promote long-term profitability. Niklas PragerPresident & CEO   For further information, please contact:Niklas Prager, President & CEO, +46 (0) 8 407 64 30Ola Burmark, CFO, +46 (0) 725 480 580 Conference call for investors, analysts and the mediaThe 2014 Financial Statement will be presented by Medivir’s President & CEO, Niklas Prager, and members of the management group.Time: Friday, 27 February 2015, at 14.00 (CET). Phone numbers for participants from:Sweden +46 (0)8 566 426 94Europe +44 20 342 81431USA +1 855 753 2236 The conference call will also be streamed via a link on the website: www.medivir.se Financial calendar:The 2014 Annual Report will be published on 7 April 2015.The Annual General Meeting will be held on 5 May 2015.The Interim Report for January–March 2015 will be published on 5 May.

Lower production and restructuring marks fourth quarter financials

Stavanger, 27 February 2015: Operating revenues for Norwegian Energy Company ASA (“Noreco”) were reduced in the fourth quarter 2014 due to low oil production. Net loss after tax was NOK 1.7 billion, impacted by several significant items, including impairments and other financial items. Operating revenues in the fourth quarter 2014 were NOK 145 million, down from NOK 255 million in the same quarter 2013. Operating income was heavily influenced by low output from the Huntington field, which only produced 616 barrels of oil equivalents per day to Noreco during the quarter, and lower realised oil price. Total impairments amounted to NOK 570 million after tax, which include NOK 241 million in write-downs after tax on Huntington and NOK 292 million in write-downs after tax on the Cecilie and Nini fields. Partial write-offs of deferred tax assets in Denmark and the UK have also impacted the net results in the quarter by NOK 618 million. Financial expenses include NOK 510 million which is related to default of all bond debt now reclassified to current liabilities. “The fourth quarter was marked by a series of events and circumstances, which prompted us to accelerate our efforts to build a new financial platform for the company. In early February we presented a restructuring proposal, which we hope that bondholders and shareholders will approve in their respective meetings on 2 and 3 March”, says Tommy Sundt, CEO of Noreco. In the report for the fourth quarter, the Board of Directors of Noreco repeats that the restructuring proposal represents the best way forward given the circumstances, as the present alternative is bankruptcy. For further information, please see the attached report for the fourth quarter 2014 and a summary presentation of the key financials. Contact:Odd Arne Slettebø, CFO. Tel.: +47 992 83 900Or email: investorrelations@noreco.com

NCC to build high eco-standard office property for KLP Eiendom in Trondheim

The Abels Hus project represents the fourth of five phases in the expansion of Trondheim’s technology village. Abels Hus will be a flexible office property with a high environmental standard. The property will be environmentally classified as Excellent according to Breeam-NOR, with a Class A energy label. “We are delighted to have signed this agreement with one of Norway’s largest and most professional property developers. Thanks to our collaboration early in the project, we have been able to develop innovative and sustainable solutions,” says Håkon Tjomsland, Business Area Manager for NCC Construction Norway. Development of the project has been in progress for six months, in which construction companies, architects, advisors and subcontractors, together with NCC, have cooperated in NCC Project Studio. This cooperation enabled an increase in the number of office workplaces, a reduction in construction costs and the implementation of additional environmental and energy-efficient solutions. Abels Hus will also be fitted with a roof of sedum (stonecrop). Sedum absorbs dust and air pollution, and also reduces drainage to the sewage network. Sedum will also have a positive impact on the biological diversity. The Abels Hus project encompasses a gross area of 19,000 square meters, and comprises six floors as well as a basement for parking and storage. The office premises will have a flexible layout, with space for up to 800 workplaces. The project is scheduled for completion in March 2017. The order will be registered during the first quarter of 2015 in the NCC Construction Norway business area. NCC Project Studio – Value-adding cooperation process The NCC Project Studio concept utilizes the collective expertise of all partners in order to jointly design the optimal end solution. Starting in August 2014, the team has focused on optimizing the premises in terms of flexibility, user-friendliness and environment.

Finnair highlights cost savings success, outlines vision for profitable growth in 2014 Annual Report

Finnair Plc Stock Exchange Release 27 February 2015 12:00  EET Finnair has published its Annual Report for 2014, measuring and accounting for the financial, economic, social and environmental performance of the Finnair Group, as well as identifying and explaining the strategic business ramifications of that performance. The major highlights of 2014 include the successful cost-savings agreements reached with the company’s employee groups that enabled Finnair to complete its ambitious program, begun in 2011, to permanently reduce annual costs by 200 million euros. As part of an effort to sustainably grow revenue while also controlling costs, Finnair also introduced several new product upgrades and service updates and began implementing its new commercial strategy. The company also began extensive preparations for the delivery of 19 Airbus A350 XWB aircraft, the first four of which are due to enter service in the second half of 2015. On 11 February Finnair published its Financial Statements for 2014, as well as the Report of the Board of Directors, Auditor’s Report, Remuneration Statement and Corporate Governance Statement. The Annual Report, which includes these documents and contains no new material information, is prepared according to G3 disclosure guidelines established by the Global Reporting Initiative (GRI). Shareholders, investors, analysts, media, customers, employees, other interested stakeholders and the general public at large comprise the report’s intended audience. Finnair has reported on environmental sustainability since 1997, and in 2008 became one of the first airlines to report according to GRI guidelines. The GRI, formed with the support of the United Nations Environment Program, is the most widely recognised international authority on sustainability reporting.  “The Annual Report is our premier forum for open, transparent engagement with all stakeholders about Finnair’s performance and value creation,” says Finnair CEO Pekka Vauramo. “In addition to detailed information and analysis, the report also takes into account larger commercial, regulatory and social trends, and explores how Finnair can succeed in the marketplace today and tomorrow. The report is addressed to all with a stake in Finnair and who care for its future.” The report is available digitally (PDF format) at www.finnairgroup.com/en

WORLD CHALLENGE EXCELS IN 2015 INTERNATIONAL SAFETY AWARDS

Whilst many companies are measured in terms of their workplace health and safety, the leading provider of experiential student travel was measured against its operational safety around its expeditions and safeguarding of participants and staff. More than 500 organisations won an International Safety Award for 2015, and the winning organisations span all sectors and range from the United Kingdom, Africa, Asia, Europe, the Middle East and the West Indies. World Challenge Global Operations Director Stuart Morris was understandably delighted with the 60 out of 60 score only a year after picking up a merit in the same category. He said: “World Challenge is committed to running the safest expeditions possible. Each year we take over 10,000 young people on educational expeditions to over 45 destinations. “We have worked hard over the last 26 years to develop an excellent reputation for our approach to safety and how we operate. “Our policies and procedures reflect industry good-practice and comply with The British Standard for Overseas Expeditions and Fieldwork (BS 8848) and Learning Outside the Classroom (LOtC). “This award is a fantastic achievement and testament to the hard work across the board.” Neal Stone, acting Chief Executive of the British Safety Council, congratulated World Challenge on its success. “On behalf of the Trustees and staff of the British Safety Council we warmly congratulate World Challenge and its employees on gaining an International Safety Award with distinction for 2015. All of those working at the company have made this award possible and they should rightly be proud of their achievement,” he added. Further information about World Challenge can be found at: www.world-challenge.co.uk  

Financial Statements 1 January - 31 December 2014, Zinzino AB (publ)

SUMMARY OF Q4, 2014 (compared with the same period in the previous year, 2013) Total revenue amounted to SEK 114.6m (82.2m), which corresponds to sales growth of 39.5 per cent for the group, compared with the previous year. Pre-tax profit amounted to SEK 5.2m (5.0m), corresponding to earnings per share of SEK 0.18 (0.17). Results were weighed down by non-recurring costs of a total of SEK 3.1m (0.0m). FOURTH QUARTER, Q4, 2014, (compared with the same period in the previous year, 2013) · Total adjusted revenue amounted to SEK 114.6m (82.2m), corresponding to growth of 39.5%. · Operating profit before depreciation amounted to SEK 7.3m (5.3m) and the operating margin before depreciation was 6.4% (6,4%). · Profit before tax amounted to SEK 5.2m (5.0m). Earnings per share before tax amounted to SEK 0.18 (0.17). · Profit after tax totalled SEK 19,5m (4.5m), which the minority interest amounts to SEK 1.5m (0.5m). Net margin 17.0% (5.5%). · Deferred tax assets on tax loss carryforwards have a positive impact of SEK 14.5m. 1 JANUARY – 31 DECEMBER 2014 (compared with the same period in the previous year, 2013) · Total adjusted revenue amounted to SEK 357.7m (254.5m), corresponding to growth of 40.5%. · Operating profit before depreciation amounted to SEK 21.4m (11.2m) and the operating margin before depreciation was 6.0% (4,4%). · Pre-tax profit tax totalled SEK 18.4m (10.4m). Diluted earnings per share before tax amounted to SEK 0.63 (0.35) after dilution. · Profit after tax amounted to SEK 32.7m (9.8m), which corresponds to a net margin of 9.1% (3.9%). Minority interest amounts to SEK 2.8m (0.8m). · Deferred tax assets on tax loss carryforwards have a positive impact of SEK 14.5m. · Liquid assets at the year-end totalled SEK 42.8m (10.9m). · The Board proposes that for the fiscal year 2014 dividend of SEK 0.25 (0.10) per share. KEY EVENTS DURING THE PERIOD 1 JANUARY - 31 DECEMBER 2014 · Admission to trading on Nasdaq OMX First North took place on 11th December 2014. The purpose of the listing was to make trading in the company's shares easier for foreign shareholders and to attract new investors. Erik Penser acts as Certified Adviser. · Zinzino AB has acquired 85% of Faun Pharma AS – an investment totalling SEK 10m. · In December 2014, Zinzino AB acquired the outstanding 90% of Bioactive Foods AS, which thus became a wholly owned subsidiary of Zinzino AB. The company has in cooperation with Zinzino developed, researched and produced Zinzino's Balance products. · New product launch: Xtender, which is designed to protect, preserve and regenerate cells and tissues. · Launch of a new flavour for BalanceOil: Orange/lemon/mint. · Investments in a new IT system have resulted in new investments of SEK 2m of which SEK 0.5m in 2014 and impairment of intangible assets of SEK 1.1m, taken as a one-time expense in the fourth quarter of 2014. · The group gained 22,738 (17,165) new customers in the fourth quarter. The sales force was expanded by 2,468 (3,057) distributors. · Turnover distribution by product area (as % of turnover) was 29% for Zinzino Coffee and 71% for Zinzino Food in the fourth quarter.   COMMENT BY CEO DAG BERGHEIM PETTERSEN: “2014 was yet another strong year and we delivered on our promise to the market of growth and improved profitability. We achieved growth of around 40% not only in the last quarter but also in the remainder of 2014 - strong figures, which are better than we had expected at the beginning of the year. Profitability also improved, with an operating margin that now exceeds 5% of our total revenue of more than SEK 350m. We consider the main factors for the improvement in profitability compared with the previous year to be our focus on growth and increased customer quotas, that is, number of customers per salesperson. I am both delighted and proud of our financial development, but even more important are perhaps the decisions on, and implementation of, the investments which will make us better equipped and more efficient in the coming years. In the final quarter of 2014 we acquired our own production capacity through the investment in Faun Pharma. In addition, we acquired 100% of Bioactive Foods AS, a company we already had a stake in. These investments will give us an excellent platform for product development and will enable us to reduce our materials costs. This, in turn, will give us a competitive advantage and improved margins, safeguarding Zinzino's operations and future. The change in trading platform to Nasdaq OMX First North is yet another important step we have taken this year and a natural step in our strategic plan concerning international expansion of the company. Currently, we are active in 12 markets. Our goal is to be established in 20 markets by 2020. In 2015, our aim is to establish operations in Germany and Canada, both countries with a large population and large potential markets for Zinzino. The expansion into both markets will be implemented in a cost-efficient manner with the help of the existing organisations in Sweden and the USA. Customer growth and improved efficiency are deeply ingrained in our culture and strategy. On the strength of all the investments carried out in 2014, in 2015 we will continue to actively work towards continued growth in all markets, integration and improved efficiency of Bioactive Foods and Faun Pharma, entering new markets, strengthening our organisation, improved IT structure, improved margins on goods sold and improved profitability. Our primary focus in 2015 is growth and many new customers. We want to achieve growth of at least 25% and an improved result every year for the next three years.” Dag Bergheim Pettersen, CEO, Zinzino AB   For a full report, please see the attached PDF. This information comprises information that Zinzino AB must disclose under the Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on27th February 2015.  INFORMATION ABOUT THE COMPANY Zinzino was founded under the name Zinzino Holding in autumn 2007. In 2009, the company acquired 93% of the equity and 97% of the votes in Zinzino Nordic AB, partly by means of a non-cash issue and partly by means of a private placement. Zinzino Nordic is a sales company that uses independent distributors to market and sell products for commission via so-called direct sales. NEXT REPORTThe Q1 quarterly report will be published on 22th May, 2015. For further information:Dag Bergheim Pettersen, CEO, Zinzino, Tel. +47(0) 93 22 57 00Fredrik Nielsen, CFO, Zinzino, Tel. +46 (0) 707 900 174Photos for publication free of charge:Anders Ekhammar, Tel. +46 (0) 707 462 579www.zinzino.se

FOURTH QUARTER AND YEAR END REPORT 2014

FOURTH QUARTER · Total revenues of $9,025’ (545’) · EBITDA of $7,356’ (-399’) · Net result of $2,120’ (-3,643’) · Earnings per share $0.07 (-0.25) TWELVE MONTHS · Total revenues of $16,200’ (2,315’) · EBITDA of $10,054’ (-681’) · Net result of $4,476’ (-3,828’) · Earnings per share $0.19 (-0.30) SIGNIFICANT EVENTS DURING THE QUARTER · Finalized and integrated the acquisition of Gas Ventures LLC. · Development program for KYTX and acquisition of neighbouring field. · Divestment of non core asset Delano. · Drilled and polymer treated Zimmerman Butte, Wyoming. · Fracking of Pieda Negra. · Drilling program commenced at Orange with GLHF #37 as the first well. · Average daily gross production of 1,204 barrels of oil equivalent (81). · OPEX (excl. production taxes and workovers) per barrel of oil equivalent amounted to $18.2. · Hedge portfolio valued to $5,659’ as per 31 December, 2014. SUBSEQUENT EVENTS · Divested non core assets Gernt. · Successful drilling of GLHF #37 with an initial daily production of 240 boe. · Successful drilling GLHF #38 and with an initial daily production of 300 boe. · Re-fracked Pieda Negra with unsuccessful result.    · Signed a Heads of Agreement with US-listed Pedevco for the sale of the US Operations. US$ Thousand Q4 Q4 FY FY  2014 2013 2014 2013Total revenues 9,025 545 16,200 2,315Revenues from oil and gas sales 2,597 395 6,964 2,166Gross profit 743 87 3,180 1,120Gross margin, % 29% 22% 46% 52%EBITDA 7,356 -399 10,054 -681EBT 2,120 -3,642 4,476 -3,811Net result 2,120 -3,643 4,476 -3,828EPS (in US$) 0.07 -0.25 0.19 -0.30Production (boepd) 1,204 81 632 69 For further information please contact: Susanna Helgesen, CFOPhone: +46 708 27 86 36US phone: +1 281 558 8585E-mail: sh@domeenergy.com About Dome EnergyDome Energy AB. is an independent Oil & Gas Company publicly traded on the Nasdaq OMX First North exchange in Sweden (Ticker: DOME (http://www.nasdaq.com/symbol/els/dome)). Remium Nordic AB is the Company’s Certified Adviser. Headquartered in Houston, Texas, the Company’s focus is on the development and production of existing onshore Oil & Gas reserves in the United States. For more information visit www.domeenergy.com.

Sanitec Corporation: Financial Statements Release 2014

Fourth quarter 2014 in brief: · Net sales for the fourth quarter amounted to EUR 156.0 million (167.5). This corresponds to a decrease of 6.9%. Comparable net sales for the fourth quarter were 3.6% lower than previous year (1). · Operating profit for the fourth quarter increased to EUR 16.3 million (14.2), 10.5% (8.5) of net sales. · Profit for the fourth quarter amounted to EUR 13.4 million (12.1). · Earnings per share, basic and diluted, were EUR 0.13 (0.12). · Cash flow from operating activities for the fourth quarter amounted to EUR 30.3 million (38.3). Full year 2014 in brief: · Net sales for the full year amounted to EUR 689.4 million (701.8). This corresponds to a decrease of 1.8%. Comparable net sales for the year were 0.7% higher than previous year (1). · Operating profit for the period amounted to EUR 78.9 million (67.9), 11.4% (9.7) of net sales. · Profit for the period amounted to EUR 45.6 million (42.5). · Earnings per share, basic and diluted, were EUR 0.46 (0.42). · Cash flow from operating activities amounted to EUR 73.8 million (74.7). · The Board of Directors proposes to the Annual General Meeting that no dividend will be distributed. (1) Calculated for comparable legal structure and in constant currency, i.e. organic change. Net sales Net sales for the fourth quarter amounted to EUR 156.0 million (167.5) which corresponds to a decrease of 6.9%. Comparable net sales for the quarter were 3.6% lower than previous year due to a negative development in four out of five regions. The impact of net foreign exchange rates in the quarter was EUR 5.6 million negative compared with previous year. Net sales for the full year 2014 amounted to EUR 689.4 million (701.8.) which corresponds to a decrease of 1.8% and an organic growth of 0.7%. The impact for the period of net foreign exchange rates was EUR 17.6 million negative compared with prior year. Net sales for Bathroom Ceramics in the fourth quarter declined organically by 4.5% to EUR 115.9 million (125.8), due to lower volume offset by better product mix and increased average sales prices. Net sales for Bathroom Ceramics for the full year amounted to EUR 521.3 million (532.1), with an organic growth for the period of 0.7%. The renewal of the product assortment that started in 2013 has continued successfully with new product introductions – including the successful introduction of the prize-winning Rimfree®toilet in several more markets. Net sales for Ceramics Complementary Products in the fourth quarter declined organically by 0.8% to EUR 40.1 million (41.7), due to still challenging market conditions for showers in certain countries, but offset by positive development for furniture, baths and prewall systems. Net sales for Ceramics Complementary Products for the full year amounted to EUR 168.1 million (169.7), with an organic growth of 0.9%. Operating profit The fourth quarter operating profit amounted to EUR 16.3 million (14.2, excluding items affecting comparability 17.9). The impact of net foreign exchange rates was EUR 0.1 million negative compared with the previous year. Operating margin for the fourth quarter amounted to 10.5% (8.5, excluding items affecting comparability 10.7). The margin was positively influenced by favourable sales mix and increased average sales prices. Furthermore, "One Sanitec" activities such as more efficient sourcing, lower costs due to previously implemented actions and continuously managed manufacturing efficiency supported the improved performance. The operating profit for the full year increased to EUR 78.9 million (67.9, excluding items affecting comparability 74.4). The operating margin for the full year increased to 11.4% (9.7, excluding items affecting comparability 10.6). The impact in the period of net foreign exchange rates was EUR 1.8 million negative compared with prior year. Public tender offer by Geberit After the reporting period Geberit has completed the acquisition of 99.2% of the shares in Sanitec and further extended the acceptance period for the remaining shareholders. Sanitec has applied for delisting of the company's shares from NASDAQ Stockholm. Last day of trading is 27 February 2015.

New members in SCA’s Corporate Senior Management Team

Ulrika Kolsrud will assume the role of President of Global Hygiene Supply Personal Care. Donato Giorgio will assume the role of President of Global Hygiene Supply Tissue. Ulrika Kolsrud and Donato Giorgio will assume their new roles effective today. This will further increase focus on achieving supply chain efficiencies. “I am happy to welcome these three new members to SCA’s Corporate Senior Management Team. Their contributions in terms of varying backgrounds, capabilities and perspectives will bring additional strength to the Group,” says Magnus Groth, President and CEO of SCA. With these appointments, Volker Zöller will leave his position as head of Regional Sales and Marketing, Central Europe at Consumer Goods Europe. Ulrika Kolsrud will leave her position as Vice President R&D at Personal Care and Donato Giorgio will leave his position as Vice President Product Supply Personal Care. “Thanks to our consistent strategy focused on innovation, growth and efficiency improvements, SCA has transformed into a leading global hygiene and forest products company. I look forward to working with our customers, partners and employees worldwide to continue executing our strategy, thereby creating further value for all our stakeholders”, says Magnus Groth. Following these changes, William Ledger, who has been instrumental in creating the foundation of a strong and efficient supply organization, will leave SCA’s Corporate Senior Management Team to pursue other opportunities within the company. NB This information is such that SCA must disclose in accordance with the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication on March 2, 2015, at 08:00 CET.

Pandox Asset Management signs first agreement

Today, Pandox’s new asset management company, Pandox Asset Management, has signed an agreement with the Norwegian property company Eiendomsspar AS, which also owns 50% of Pandox AB, to assume the management of the majority of Eiendomsspar’s hotel properties. The commission includes eight hotel properties with a total of 1,500 rooms, all of them in Oslo. – We look forward to developing a close relationship with Eiendomsspar and to the prestigious assignment to manage and develop their hotel properties. This agreement is part of the company’s new strategy to manage hotel properties for other owners than Pandox and we look forward to finding more opportunities of a similar nature, says Anders Nissen, CEO, Pandox. The agreement covers the following hotel properties: · Clarion Collection Gabelshus, 114 rooms · Clarion Collection Folketeatret, 160 rooms · Scandic Gardermoen, 135 rooms · Scandic Helsfyr, 253 rooms · Scandic Holberg, 133 rooms · Scandic Holmenkollen Park, 336 rooms · Scandic Oslo City, 175 rooms · Scandic Victoria, 199 rooms Pandox Asset Management – offer: · Regular updates on market developments · Access to the knowledge and resources of Pandox’s own operations management organisation · Hotel market analysis and property development · Communication and cooperation with the operator as well as negotiations to secure market level agreements · Risk limitation: ability to assume operations and secure the value of the property · Analysis and evaluation of rental incomes. Ensure that quality reports are produced · Production of written plans for operations and maintenance, and full responsibility for their effective execution · Analysis and recommendations of investments aimed to maximise potential while limiting risks FOR FURTHER INFORMATION, PLEASE CONTACT: Anders Nissen, CEO Pandox AB+46 708 46 02 02anders.nissen@pandox.se Leif Kristen Olsen, Vice President, Area Manager, Norway and Sweden+47 909 99 603leif.kristen.olsen@pandox.se

£10m for new officers’ rooms at Catterick

The Defence Infrastructure Organisation (DIO) has completed a £10m project to provide two new accommodation blocks for officers at Vimy Barracks, Catterick Garrison. An increase in the number of officers based at the Infantry Training Centre (ITC) at Catterick led to a requirement to build two new Single Living Accommodation (SLA) blocks. There are 114 rooms for junior officers in one block and 42 for senior officers in the second. Other facilities include a laundry room, drying room and snack preparation areas. Mike Reynolds, DIO Project Manager, said: “DIO is here to provide the right buildings in the right places for defence, so I’m really pleased to have been involved in this build. These modern accommodation blocks will improve the lives of officers living there and should therefore help them to provide top-notch training to the next generation of infantry soldiers.” Lieutenant Colonel Angus Philp, Commanding Officer, Infantry Training Centre Support Battalion, said: “These blocks significantly improve the standard of accommodation for staff at the ITC. This is an important part of investing in our people and making the experience of working here enjoyable as well as rewarding.” The contract was awarded to Debut Services Ltd, a joint venture between Lend Lease and Babcock, in December 2012 and work commenced on site in April 2013. The work required the construction of a new car park on the site of an existing annexe, which was demolished. Ends

Mauricio Ramos appointed Millicom’s Chief Executive Officer

Mauricio was most recently President of Liberty Global's Latin American Division, a position he held from 2006 until February 2015. Over the past fourteen years he has held a number of leadership roles at Liberty Global, including positions as Chairman and CEO of VTR in Chile, CFO of Liberty's Latin American Division and President of Liberty Puerto Rico. Throughout this period he has successfully developed both mobile and broadband businesses in Latin America, delivering solid operational improvement and outstanding financial results. Mauricio is also Chairman of TEPAL, the Latin American Association of Cable Broadband Operators. He is a Colombian national who received a degree in Economics, a degree in Law and a postgraduate degree in Financial Law from Universidad de los Andes in Bogota. Cristina Stenbeck said "The Board is pleased to announce the appointment of Mauricio Ramos as CEO of Millicom. He is a talented and experienced world-class professional, with a deep understanding of the digital consumer. He will bring the vision, leadership and execution capability necessary to further develop our strong Tigo franchise and create long term shareholder value.” Mauricio Ramos commented “I am absolutely thrilled to have been asked to become Millicom’s CEO. I have long admired the company’s innovative strategy, strong market positions, entrepreneurial spirit and talented professionals. I am looking forward to working with the Millicom team, the Board of Directors and partners to further develop an outstanding company, with very promising opportunities. I look forward to continuing to bring Tigo's innovative products and services to customers and their communities while delivering superior returns to its shareholders.” Cristina Stenbeck added "On behalf of my fellow Board members I would like to take this opportunity to thank Millicom’s CFO, Tim Pennington, who has acted as Interim CEO over the last few months. Under Tim’s leadership the company continued to execute its strategy, strengthen its core business and deliver a solid set of financial results. We are very grateful for Tim’s deep engagement and additional commitment during this transition period and we look forward to his continued contribution in his role as CFO and as an integral part of the Millicom leadership team.”